<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: "…"
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>WO1999006541A1 - Antihuman pre-b cell receptor antibodies 
        - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/WO1999006541A1/en">
    <meta name="description" content="
     An antibody recognizing a human pre-B cell receptor but not a human pro-B cell; an antibody reacting with a V pre-B molecule which is one of the constituents of the SL chain of a human pre-B cellreceptor expressed on the surface of the membrane of a human pre-B cell or with a V pre-B cell expressed in a human pro-B cell, but not with a μ5 molecule in a replacing light chain and showing a reactivity to such an extent that the human pre-B cell or human pro-B cell thus reacted with the antibody can be detected under a microscope; and a method for judging the B-cell differentiation step causative of acute lymphatic leukemia of infant by using the antibody recognizing a human pre-B cell receptor but not a human pro-B cell, an antibody recognizing a V pre-B molecule in a replacing light chain consitituting a human pre-B cell receptor, an antibody recognizing a μ5 molecule in a replacing light chain constituting a human pre-B cell receptor, and an antibody recognizing a B cell. 
   
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="Antihuman pre-b cell receptor antibodies 
       ">
    <meta name="DC.date" content="1998-07-29" scheme="dateSubmitted">
    <meta name="DC.description" content="
     An antibody recognizing a human pre-B cell receptor but not a human pro-B cell; an antibody reacting with a V pre-B molecule which is one of the constituents of the SL chain of a human pre-B cellreceptor expressed on the surface of the membrane of a human pre-B cell or with a V pre-B cell expressed in a human pro-B cell, but not with a μ5 molecule in a replacing light chain and showing a reactivity to such an extent that the human pre-B cell or human pro-B cell thus reacted with the antibody can be detected under a microscope; and a method for judging the B-cell differentiation step causative of acute lymphatic leukemia of infant by using the antibody recognizing a human pre-B cell receptor but not a human pro-B cell, an antibody recognizing a V pre-B molecule in a replacing light chain consitituting a human pre-B cell receptor, an antibody recognizing a μ5 molecule in a replacing light chain constituting a human pre-B cell receptor, and an antibody recognizing a B cell. 
   
   ">
    <meta name="citation_patent_application_number" content="PC:T/JP1998/003384">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/47/82/6d/591bc07b1bd13b/WO1999006541A1.pdf">
    <meta name="citation_patent_publication_number" content="WO:1999006541:A1">
    <meta name="DC.date" content="1999-02-11">
    <meta name="DC.contributor" content="Keiko Tsuganezawa" scheme="inventor">
    <meta name="DC.contributor" content="Hajime Karasuyama" scheme="inventor">
    <meta name="DC.contributor" content="Sumitomo Electric Industries, Ltd." scheme="assignee">
    <meta name="citation_reference" content="GUELPA-FONLUPT V, ET AL.: &quot;DISCRETE EARLY PRO-B AND PRE-B STAGES IN NORMAL HUMAN BONE MARROW AS DEFINED BY SURFACE PSEUDO-LIGHT CHAIN EXPRESSION&quot;, EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY - V C H VERLAG GMBH &amp; CO. KGAA, DE, vol. 24, no. 04, 1 January 1994 (1994-01-01), DE, pages 257 - 264, XP002920269, ISSN: 0014-2980, DOI: 10.1002/eji.1830240140" scheme="references">
    <meta name="citation_reference" content="LASSOUED K, ET AL.: &quot;EXPRESSION OF SURROGATE LIGHT CHAIN RECEPTORS IS RESTRICTED TO A LATE STAGE IN PRE-B CELL DIFFERENTIATION&quot;, CELL, CELL PRESS, US, vol. 73, no. 01, 9 September 1993 (1993-09-09), US, pages 73 - 86, XP002920267, ISSN: 0092-8674, DOI: 10.1016/0092-8674(93)90161-I" scheme="references">
    <meta name="citation_reference" content="MEFFRE E, ET AL.: &quot;CELL SURFACE EXPRESSION OF SURROGATE LIGHT CHAIN (PSIL) IN THE ABSENCE OF MU ON HUMAN PRO-B CELL LINES AND NORMAL PRO-B CELLS&quot;, EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY - V C H VERLAG GMBH &amp; CO. KGAA, DE, vol. 26, no. 09, 1 January 1996 (1996-01-01), DE, pages 2172 - 2180, XP002920270, ISSN: 0014-2980, DOI: 10.1002/eji.1830260932" scheme="references">
    <meta name="citation_reference" content="SANZ E, HERA DE LA A: &quot;A NOVEL ANTI-VPRE-B ANTIBODY IDENTIFIES IMMUNOGLOBULIN-SURROGATE RECEPTORS ON THE SURFACE OF HUMAN PRO-B CELLS&quot;, THE JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, US, vol. 183, no. 06, 1 January 1996 (1996-01-01), US, pages 2693 - 2698, XP002920268, ISSN: 0022-1007, DOI: 10.1084/jem.183.6.2693" scheme="references">
    <meta name="citation_reference" content="See also references of EP 1001020A4" scheme="references">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            Antihuman pre-b cell receptor antibodies 
       </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA68376881" lang="EN" load-source="patent-office" class="style-scope patent-text">
    <div class="abstract style-scope patent-text">An antibody recognizing a human pre-B cell receptor but not a human pro-B cell; an antibody reacting with a V pre-B molecule which is one of the constituents of the SL chain of a human pre-B cellreceptor expressed on the surface of the membrane of a human pre-B cell or with a V pre-B cell expressed in a human pro-B cell, but not with a μ5 molecule in a replacing light chain and showing a reactivity to such an extent that the human pre-B cell or human pro-B cell thus reacted with the antibody can be detected under a microscope; and a method for judging the B-cell differentiation step causative of acute lymphatic leukemia of infant by using the antibody recognizing a human pre-B cell receptor but not a human pro-B cell, an antibody recognizing a V pre-B molecule in a replacing light chain consitituting a human pre-B cell receptor, an antibody recognizing a μ5 molecule in a replacing light chain constituting a human pre-B cell receptor, and an antibody recognizing a B cell.</div>
  </abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/00"><a id="link" href="#" class="style-scope state-modifier">G01N33/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/48"><a id="link" href="#" class="style-scope state-modifier">G01N33/48</a></state-modifier>
                  <span class="description style-scope classification-tree">Biological material, e.g. blood, urine; Haemocytometers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/50"><a id="link" href="#" class="style-scope state-modifier">G01N33/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/53"><a id="link" href="#" class="style-scope state-modifier">G01N33/53</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoassay; Biospecific binding assay; Materials therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/569"><a id="link" href="#" class="style-scope state-modifier">G01N33/569</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/56966"><a id="link" href="#" class="style-scope state-modifier">G01N33/56966</a></state-modifier>
                  <span class="description style-scope classification-tree">Animal cells</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="G01N33/56972"><a id="link" href="#" class="style-scope state-modifier">G01N33/56972</a></state-modifier>
                  <span class="description style-scope classification-tree">White blood cells</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K16/00"><a id="link" href="#" class="style-scope state-modifier">C07K16/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K16/18"><a id="link" href="#" class="style-scope state-modifier">C07K16/18</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K16/28"><a id="link" href="#" class="style-scope state-modifier">C07K16/28</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 1 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Life Sciences &amp; Earth Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Life Sciences &amp; Earth Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">WO1999006541A1</h2>
                  <p class="tagline style-scope patent-result">WIPO (PCT)</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">International application published with international search report</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/47/82/6d/591bc07b1bd13b/WO1999006541A1.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;antibody&quot;,&quot;human&quot;,&quot;cells&quot;,&quot;cell&quot;,&quot;pro&quot;]" data-before="19970729"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/WO1999006541A1"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1999006541A1/fr"><a id="link" href="#" class="style-scope state-modifier">French</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1999006541A1/ja"><a id="link" href="#" class="style-scope state-modifier">Japanese</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Keiko Tsuganezawa"><a id="link" href="#" class="style-scope state-modifier">Keiko Tsuganezawa</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Hajime Karasuyama"><a id="link" href="#" class="style-scope state-modifier">Hajime Karasuyama</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1998</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO1999006541A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline" this="">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/JP1998/003384</div>
                <div class="style-scope application-timeline">Filing date: 1998-07-29</div>
                <div class="style-scope application-timeline">Legal status: Application Discontinuation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP1001020A4/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP98935272A</div>
                <div class="style-scope application-timeline">Filing date: 1998-07-29</div>
                <div class="style-scope application-timeline">Legal status: Withdrawn</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2000</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US6335175B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US09/494,252</div>
                <div class="style-scope application-timeline">Filing date: 2000-01-31</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application PCT/JP1998/003384 events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline"><div date="" class="external-priority style-scope application-timeline">1997-07-29</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JPH1142087A/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority claimed from JP9202684A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline"><div date="" class="external-priority style-scope application-timeline">1997-10-29</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JPH11133028A/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority claimed from JP29609097A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">1998-07-29</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Sumitomo Electric Industries, Ltd."><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Sumitomo Electric Industries, Ltd.</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="priority style-scope application-timeline">1998-07-29</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP1001020A4/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority to EP98935272A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">1999-02-11</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO1999006541A1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of WO1999006541A1</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline"><div date="" class="priority style-scope application-timeline">2000-01-31</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US6335175B1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority to US09/494,252</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (3)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#nplCitations" class="style-scope patent-result">Non-patent citations (5)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (15)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=WO&amp;NR=9906541A1&amp;KC=A1&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/WO/1999006541/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patentscope.wipo.int/search/en/WO1999006541">PatentScope</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/WO1999006541A1">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PDES133036170" lang="EN" load-source="WIPO-OCR" class="description style-scope patent-text">
  
  <div id="p0001" num="0001" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 明糸田書 </span>&nbsp;Akitoda</span>
  </div>
  <div id="p0002" num="0002" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 抗ヒトプレ B細胞レセプ夕一抗体 </span>&nbsp;Anti-human pre-B cell receptor Yuichi antibody</span>
  </div>
  <div id="p0003" num="0003" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">技術分野 </span>Technical field </span>
  </div>
  <div id="p0004" num="0004" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 本発明は、 ヒトブレ B細胞レセプ夕一を認識する抗体に関する。 また、 ヒトプ レ B細胞の膜表面に発現しているヒトプレ B細胞レセプ夕一の代替軽鎖の Vpr eB分子、 プレ Bの細胞内の Vp r eBおよびヒトプロ B細胞の細胞内に発現し ている Vp r eB分子に反応する抗体またはその活性フラグメントに関する。 ま た、 本発明は、 サポニン緩衝液を用いて、 前記抗体またはその活性フラグメント によりヒトプロ B細胞及びヒトプレ B細胞を検出する検出方法に関する。 本発明 の抗体は、 急性リンパ性白血病の診断に応用できる。 </span>&nbsp;The present invention relates to an antibody that recognizes human Bleeve receptor. In addition, human pre-B cell receptor expressed on the membrane surface of human pre-B cells, VprEB molecule of alternative light chain of receptor, VpreB in pre-B cells and expressed in human pro-B cells It relates to an antibody or an active fragment thereof that reacts with a VpreB molecule. In addition, the present invention relates to a detection method for detecting human pro-B cells and human pre-B cells with the antibody or an active fragment thereof using a saponin buffer. The antibody of the present invention can be applied to diagnosis of acute lymphocytic leukemia.</span>
  </div>
  <div id="p0005" num="0005" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">背景技術 </span>Background art</span>
  </div>
  <div id="p0006" num="0006" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> B細胞は、 骨髄の造血幹細胞からプロ B細胞、 プレ B細胞、 未熟 B細胞、 成 熟 B細胞の各段階を経て形質細胞に分化することが知られている。 </span>&nbsp;B cells are known to differentiate from bone marrow hematopoietic stem cells into plasma cells through each stage of pro-B cells, pre-B cells, immature B cells, and mature B cells.</span>
  </div>
  <div id="p0007" num="0007" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> B細胞の表面には抗原認識レセプ夕一として免疫グロブリン （以下、 I gと 記載することがある） が発現している。 この抗原認識レセプ夕一は、 重鎖と軽鎖 の 2種のポリペプチドから構成されているが、 B細胞の分化につれて、 その構成 が変化する。 </span>&nbsp;Immunoglobulin (hereinafter, sometimes referred to as Ig) is expressed on the surface of B cells as an antigen recognition receptor. This antigen recognition receptor is composed of two types of polypeptides, a heavy chain and a light chain, and the composition changes as B cells differentiate.</span>
  </div>
  <div id="p0008" num="0008" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 以下にマウスを例として、 B細胞の分化とその抗原認識レセプ夕一について 説明する。 </span>&nbsp;In the following, the differentiation of B cells and their antigen recognition receptor will be described using a mouse as an example.</span>
  </div>
  <div id="p0009" num="0009" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> プロ B細胞では、 代替重鎖 （SH鎖） と呼ばれる重鎖 （H鎖） に、 人 5および</span>&nbsp;In pro B cells, human 5 and heavy chains (H chains), called alternative heavy chains (SH chains)</span>
  </div>
  <div id="p0010" num="0010" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Vpr eBと呼ばれる二つのポリペプチドが会合した代替軽鎖 （サロゲイ トライ ト鎖 （SL鎖） ） が会合して細胞表面に発現していることが知られている。 代替 軽鎖は、 λ5分子 （以下入 5ということがある） と VpreB分子 （以下 Vpr eBということがある） が会合して通常の軽鎖 （L鎖） の代わりをすることから そう呼ばれている。 λ 5が軽鎖の定常領域に相当し、 VpreBが軽鎖の可変領 域に相当する。 

 プレ B細胞では、 プレ B細胞レセプ夕一が細胞表面に発現していることが知 られている。 プレ B細胞レセプ夕一は、 〃鎖と呼ばれる重鎖 （H鎖） に、 人 5お よび V p r eBと呼ばれる二つのポリぺプチドが会合した代替軽鎖 ( S L鎖） が 会合している。 </span>It is known that a surrogate light chain (SL chain), an alternative light chain in which two polypeptides called VpreB are associated, is expressed on the cell surface. The alternative light chain is so called because the λ5 molecule (hereinafter sometimes referred to as “5”) and the VpreB molecule (hereinafter sometimes referred to as “VpreB”) associate and replace the normal light chain (L chain). I have. λ5 corresponds to the constant region of the light chain, and VpreB corresponds to the variable region of the light chain.  In pre-B cells, it is known that pre-B cell receptor is expressed on the cell surface. In the pre-B cell receptor, a light chain (H chain) called 〃 chain and an alternative light chain (SL chain) in which two polypeptides called V preB are associated with a heavy chain (H chain).</span>
  </div>
  <div id="p0011" num="0011" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 未熟 B細胞および成熟 B細胞では、 抗原認識レセプ夕一として、 //鎖に通常 の L鎖が結合した B細胞レセプ夕一が発現している。 </span>&nbsp;In immature B cells and mature B cells, a B cell receptor with a normal L chain attached to the // chain is expressed as an antigen recognition receptor.</span>
  </div>
  <div id="p0012" num="0012" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 前記からわかるように、 人5ぉょび 68は、 プロ B細胞およびプレ B 細胞にのみ細胞に発現する。 </span>&nbsp;As can be seen from the foregoing, human 5 and 68 are only expressed on pro-B cells and pre-B cells.</span>
  </div>
  <div id="p0013" num="0013" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ヒトプレ B細胞レセプ夕一についても、 前記と同様の知見が報告されている。 従来、 ヒトプレ B細胞レセプ夕一と反応する抗体としては、 以下に示すものが 知られている。 それぞれの反応性等を表 1に示す。 </span>&nbsp;Similar findings have been reported for human pre-B cell receptor Yuichi. Conventionally, the following antibodies are known to react with human pre-B cell receptor. Table 1 shows the reactivity and the like.</span>
  </div>
  <div id="p0014" num="0014" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ①抗ヒ卜プレ B細胞レセプ夕一抗体： SLC 1、 SLC2, SLC3、 SL C4 (Ce l l, 73巻、 73— 86ページ、 1993年） </span>&nbsp;(1) Anti-human pre-B cell receptor antibody: SLC1, SLC2, SLC3, SLC4 (Cell, 73, 73-86, 1993)</span>
  </div>
  <div id="p0015" num="0015" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ②抗ヒトプレ B細胞レセプ夕一抗体： 9 C 2 (Eur. J. Immuno 1 o. 、 24卷、 257— 264ページ、 1994年） </span>&nbsp;②Anti-human pre-B cell receptor antibody: 9C2 (Eur. J. Immunol o., 24, 257-264, 1994)</span>
  </div>
  <div id="p0016" num="0016" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ③抗ヒト Vp r eB抗体： 3C7、 6 F 6 (Eur. J. Immuno 1 o. 、 26巻、 2172— 2180ページ、 1996年） </span>&nbsp;3) Anti-human Vpr eB antibody: 3C7, 6F6 (Eur. J. Immunol o., 26, 2172—2180, 1996)</span>
  </div>
  <div id="p0017" num="0017" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ④抗ヒト Vp r eB抗体： B— MAD 176、 B— MAD 688、 B-MA D 792、 B - MAD 1112 (J. Exp. Med. , 183卷、 2693 - 2698ページ、 1996年） 

</span>④Anti-human VprEB antibody: B—MAD176, B—MAD688, B-MAD792, B-MAD1112 (J. Exp. Med., 183, 2693-2698, 1996) </span>
  </div>
  <div id="p0018" num="0018" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">表 1 </span>table 1 </span>
  </div>
  <div id="p0019" num="0019" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text">
      <span class="google-src-text style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/82/bc/e9/3ac5658dc08320/imgf000005_0001.png" class="style-scope patent-text"><img id="imgf000005_0001" he="105" wi="225" file="imgf000005_0001.tif" img-format="tif" img-content="drawing" orientation="landscape" inline="no" width="900" height="420" alt="Figure imgf000005_0001" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/82/bc/e9/3ac5658dc08320/imgf000005_0001.png"></a></div>
        
      </span>
      <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/82/bc/e9/3ac5658dc08320/imgf000005_0001.png" class="style-scope patent-text"><img id="imgf000005_0001" he="105" wi="225" file="imgf000005_0001.tif" img-format="tif" img-content="drawing" orientation="landscape" inline="no" width="900" height="420" alt="Figure imgf000005_0001" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/82/bc/e9/3ac5658dc08320/imgf000005_0001.png"></a></div>
      
    </span>
  </div>
  <div id="p0020" num="0020" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">T </span>T</span>
  </div>
  <div id="p0021" num="0021" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">発明の開示 </span>Disclosure of the invention</span>
  </div>
  <div id="p0022" num="0022" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> B細胞分化の異常は、 白血病を引き起こす。 B細胞が分化のどの段階で異常増 殖したかを知ることは、 白血病の治療上重要である。 特に、 小児の急性リンパ性 白血病では、 プロ B細胞あるいはプレ B細胞の異常増殖が原因であることが多い。 現在、 一般的に診断で使われている B細胞表面マーカ一としては、 抗 C D 1 0抗 体、 抗 C D 1 9抗体、 抗 C D 2 0抗体、 抗 C D 2 1抗体がある。 これらの抗体を B細胞と反応させ、 その結果により、 当該 B細胞がどの段階のものか知ろうとし ている。 しかし、 抗 C D 1 9抗体、 抗 C D 2 0抗体および抗 C D 2 1抗体は未熟 B細胞や成熟 B細胞とも反応し、 抗 C D 1 0抗体は T細胞や上皮細胞にも反応す る。 したがって、 これらの抗体では、 ヒトプロ B細胞またはヒトプレ B細胞のみ を特異的に検出することは不可能であった。 </span>&nbsp;Abnormal B cell differentiation causes leukemia. Knowing at what stage of differentiation B cells abnormally proliferate is important in the treatment of leukemia. In particular, acute lymphoblastic leukemia in children is often caused by abnormal proliferation of pro-B or pre-B cells. Currently, B cell surface markers generally used for diagnosis include anti-CD10 antibody, anti-CD19 antibody, anti-CD20 antibody, and anti-CD21 antibody. These antibodies are reacted with B cells, and as a result, they are trying to know the stage of the B cells. However, anti-CD19, anti-CD20 and anti-CD21 antibodies also react with immature and mature B cells, and anti-CD10 antibodies also react with T cells and epithelial cells. Therefore, it was impossible for these antibodies to specifically detect only human pro-B cells or human pre-B cells.</span>
  </div>
  <div id="p0023" num="0023" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 本発明は、 ヒトプレ B細胞レセプ夕一を認識しかつヒトプロ B細胞を認識しな い抗体を提供し、 もってヒトプレ B細胞とヒトプロ B細胞とを区別して、 ヒトプ レ B細胞またはヒトプレ B細胞を特異的に検出することを可能にすることを課題 とする。 </span>&nbsp;The present invention provides an antibody that recognizes human pre-B cell receptor but does not recognize human pro-B cell, thereby distinguishing between human pre-B cell and human pro-B cell and specifying human pre-B cell or human pre-B cell. It is an object to make it possible to detect in a targeted manner.</span>
  </div>
  <div id="p0024" num="0024" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 臨床診断の場においては、 細胞を顕微鏡で観察することが行われている。 他の 方法に比し、 最も簡便かつ速く、 さらに設備の設置場所が最小限ですむ方法であ るからである。 しかし、 細胞の染色が非常に弱い場合は、 F A C Sのような高精 度の検出方法では検出できても、 顕微鏡では観察することができない。 上記①〜 ④に挙げたヒトプレ B細胞レセプ夕一等に対する抗体、 特に V p r e Bに対する 抗体はいずれも、 F A C Sの結果が示されているのみである。 すなわち、 該抗体 に反応した細胞を顕微鏡で観察することが可能な程度に染色することができる程 度の反応性のあるものかどうか示されていない。 また、 ヒトプロ B細胞との反応 性も、 細胞表面の反応性が示されているだけであり、 細胞内染色については示さ れていない。 </span>&nbsp;In the field of clinical diagnosis, observation of cells with a microscope is performed. This is because it is the simplest and fastest method compared to other methods, and requires only minimal installation space. However, if the staining of the cells is very weak, they cannot be observed with a microscope even if they can be detected with a high-precision detection method such as FACS. Antibodies against human pre-B cell receptor such as those described in (1) to (4) above, particularly antibodies against VprEB, only show FACS results. That is, it is not shown whether the cells react with the antibody and have enough reactivity to be stained to the extent that they can be observed with a microscope. In addition, the reactivity with human pro-B cells only shows the reactivity on the cell surface, but does not show the intracellular staining.</span>
  </div>
  <div id="p0025" num="0025" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 本発明は、 ヒトプレ B細胞およびヒトプロ B細胞と特異的に反応する抗体であ 

つて、 ヒトプレ B細胞レセプ夕一を膜表面に発現しているヒトプレ B細胞および Vpr eB分子を細胞内に発現しているヒトプロ B細胞を該抗体により免疫染色 して、 免疫染色された細胞のみを顕微鏡で観察することが可能である抗体を提供 することを課題とする。 </span>The present invention relates to an antibody that specifically reacts with human pre-B cells and human pro-B cells.  Then, human pre-B cells expressing human pre-B cell receptors on the membrane surface and human pro-B cells expressing VpreB molecules in the cells were immunostained with the antibody, and only the immunostained cells were detected. It is an object to provide an antibody which can be observed with a microscope.</span>
  </div>
  <div id="p0026" num="0026" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 本発明は、 以上の課題を解決するために、 ヒトプレ B細胞レセプ夕一を認識し かつヒトプロ B細胞を認識しない抗体を提供する。 本発明の抗体は、 ヒトプレ B 細胞の 鎖、 人 5および VpreBがなす立体構造を認識する抗体ならびにヒトプレ B細胞の膜表面に発現しているヒトプレ B細胞レセプ夕一の SL鎖の構成員の一 つである Vp r eB分子またはヒトプロ B細胞内に発現している V p r e B分子 と反応し、 λ 5分子とは反応せず、 かつその反応性が、 該抗体が反応したヒトブ レ Β細胞またはヒトプロ Β細胞を顕微鏡で検出することが可能な程度の反応性で ある抗体である。 </span>&nbsp;The present invention provides an antibody that recognizes human pre-B cell receptors and does not recognize human pro-B cells in order to solve the above problems. The antibody of the present invention is an antibody that recognizes the three-dimensional structure formed by human pre-B cell chains, human 5 and VpreB, and one of the members of the SL chain of human pre-B cell receptor expressed on the membrane surface of human pre-B cells. Reacts with the VpreB molecule or the VpreB molecule expressed in human pro-B cells, but does not react with the λ5 molecule, and the reactivity of the molecule does not react with the human pre-B cells. It is an antibody that is reactive enough to detect human prostate cells with a microscope.</span>
  </div>
  <div id="p0027" num="0027" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> さらに、 本発明は、 ハイプリ ドーマ HSL2 (日本国茨城県つくば巿東 1丁目 1番 3号、 通商産業省工業技術院生命工学工業技術研究所に、 受託番号 FERM —Ρ 16476で平成 9年 10月 16日に原寄託し、 さらに平成 10年 5月 25 曰に、 国際寄託当局である曰本国茨城県つくば巿東 1丁目 1番 3号、 通商産業省 工業技術院生命工学工業技術研究所に、 受託番号 FERM— BP 6378で移管 した。 ） が産生するモノクローナル抗体またはその活性フラグメントである請求 項 1に記載の抗ヒトプレ B細胞レセプ夕一抗体を提供するものである。 </span>&nbsp;In addition, the present invention was applied to Hypri-Doma HSL2 (1-3 1-3 Tsukuba-Higashi, Ibaraki Pref., Japan, Institute of Biotechnology, Industrial Science and Technology, Ministry of International Trade and Industry, Ministry of International Trade and Industry under the accession number FERM —Ρ 16476, October 1997). The original deposit was deposited on 16th, and on May 25, 1998, the International Depositary Authority, 1-3-1, Tsukuba-Higashi, Ibaraki, Japan, and the Ministry of International Trade and Industry, National Institute of Biotechnology and Industrial Technology, 2. The anti-human pre-B cell receptor antibody according to claim 1, which is a monoclonal antibody or an active fragment thereof produced by accession number FERM-BP 6378.</span>
  </div>
  <div id="p0028" num="0028" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> さらに、 本発明は、 ハイプリ ドーマ HSL96 (日本国茨城県つくば市東 1丁 目 1番 3号、 通商産業省工業技術院生命工学工業技術研究所に、 受託番号 FER M-P 16251で平成 9年 5月 30曰に原寄託し、 さらに平成 10年 5月 25 曰に、 国際寄託当局である曰本国茨城県つくば巿東 1丁目 1番 3号、 通商産業省 工業技術院生命工学工業技術研究所に、 受託番号 FERM— BP 6375で移管 した。 ） が産生するモノクローナル抗体またはその活性フラグメントである上記 記載の抗体またはその活性フラグメントを提供するものである。 

 さらに、 本発明は、 上記記載の抗体またはその活性フラグメントにより検体中 のヒトプロ B細胞を免疫染色して該ヒトプロ B細胞を検出するヒトプロ B細胞の 検出方法であって、 ヒトプロ B細胞内の Vp r eB分子を免疫染色するときにサ ポニン緩衝液を用いることを特徴とするヒトプロ B細胞の検出方法を提供するも のである。 </span>In addition, the present invention was applied to Hypri-Doma HSL96 (1-3 1-3, Higashi, Tsukuba, Ibaraki, Japan, Research Institute of Biotechnology, Industrial Science and Technology, Ministry of International Trade and Industry under the accession number FER MP 16251, May 30, 1997). May 25, 1998, said that the depositary authority was the International Depository Authority, 1-3-1, Tsukuba-Higashi, Ibaraki, Japan, and contracted to the Institute of Biotechnology and Industrial Technology, Ministry of International Trade and Industry, Ministry of International Trade and Industry. No. FERM—transferred with BP 6375.) provides the above-described antibody or an active fragment thereof, which is a monoclonal antibody or an active fragment thereof produced by  Furthermore, the present invention provides a method for detecting human pro-B cells by immunostaining human pro-B cells in a specimen with the above-described antibody or an active fragment thereof, the method comprising detecting Vpr in human pro-B cells. Another object of the present invention is to provide a method for detecting human pro-B cells, which comprises using a saponin buffer when immunostaining an eB molecule.</span>
  </div>
  <div id="p0029" num="0029" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> また、 本発明は、 小児急性リンパ性白血病が B細胞のどの分化段階由来である かを診断する診断薬であって、 （1)ヒトプレ B細胞レセプ夕一を認識し、 且つヒ トプロ B細胞を認識しない抗体、 （2)ヒトプレ B細胞レセプ夕一を構成する代替 軽鎖の Vr e pB分子を認識する抗体、 （3)ヒトプレ B細胞レセプ夕一を構成す る代替軽鎖の人 5分子を認識する抗体、 および（4)B細胞を認識する抗体を少な くとも含むことを特徴とする診断薬を提供するものである。 </span>&nbsp;The present invention also relates to a diagnostic agent for diagnosing which stage of B cell differentiation pediatric acute lymphoblastic leukemia is derived from, and (1) recognizing human pre-B cell receptor; An antibody that does not recognize, (2) an antibody that recognizes the alternative light chain VrepB molecule that forms the human pre-B cell receptor, and (3) an alternative light chain human molecule that forms the human pre-B cell receptor. It is intended to provide a diagnostic agent comprising at least an antibody recognizing and (4) an antibody recognizing B cells.</span>
  </div>
  <div id="p0030" num="0030" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> さらに、 本発明は、 ヒトプレ B細胞レセプ夕一を認識し且つヒトプロ B細胞を 認識しない抗体、 ヒトプレ B細胞レセプ夕一を構成する代替軽鎖の Vr e pB分 子を認識する抗体、 ヒトプレ B細胞レセプ夕一を構成する代替軽鎖の人 5分子を 認識する抗体、 および B細胞を認識する抗体を使用して、 小児急性リンパ性白血 病が B細胞のどの分化段階由来であるかを診断する方法を提供するものである。 図面の簡単な説明 </span>&nbsp;Further, the present invention relates to an antibody that recognizes human pre-B cell receptor but does not recognize human pro-B cells, an antibody that recognizes VrepB molecules of an alternative light chain constituting human pre-B cell receptor, human pre-B cells Diagnose which stage of B cell differentiation pediatric acute lymphoblastic leukemia is using antibodies that recognize the five human alternative light chain molecules that make up the receptor and antibodies that recognize B cells It provides a method. BRIEF DESCRIPTION OF THE FIGURES</span>
  </div>
  <div id="p0031" num="0031" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 1図は、 本発明の抗体を作製するために免疫原に用いたキメラのプレ B細胞 レセプ夕一 （マウス〃鎖/ヒト人 5/ヒト Vpr eB)の電気泳動写真である。 第 2図は、 免疫沈降によるスクリーニングで選択されたハイプリ ドーマの培養 上清を用いた免疫沈降物の電気泳動の結果を表す電気泳動写真である。 </span>&nbsp;FIG. 1 is an electrophoresis photograph of chimeric pre-B cell receptor Yuichi (mouse 〃 chain / human 5 / human VpreB) used as an immunogen to produce the antibody of the present invention. FIG. 2 is an electrophoretic photograph showing the results of electrophoresis of an immunoprecipitate using a culture supernatant of a hybridoma selected by immunoprecipitation screening.</span>
  </div>
  <div id="p0032" num="0032" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 3図は、 第 3 A図〜第 3 C図の配置を示す図である。 </span>&nbsp;FIG. 3 is a diagram showing the arrangement of FIGS. 3A to 3C.</span>
  </div>
  <div id="p0033" num="0033" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">第 3 A図は、 プレ B細胞レセプ夕一に対する本発明の HS L 2抗体および HSL 96抗体、 HSL 11抗体、 抗ヒト 鎖抗体ならびに抗ヒト人鎖抗体のそれぞれ の E L I S Aの結果を示す図である。 </span>FIG. 3A is a view showing the results of ELISA for the HS L2 antibody, HSL 96 antibody, HSL 11 antibody, anti-human chain antibody, and anti-human chain antibody of the present invention for pre-B cell receptors. .</span>
  </div>
  <div id="p0034" num="0034" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 3B図は、 ヒト I gM (ヒト〃鎖およびヒト 鎖） に対する本発明の HSL 

 2抗体および HSL 96抗体、 HSL 11抗体、 抗ヒト/ c鎖抗体ならびに抗ヒト え鎖抗体のそれぞれの EL I S Aの結果を示す図である。 </span>FIG. 3B shows the HSL of the present invention against human IgM (human 〃 chain and human chain).  FIG. 2 shows the results of ELISA for antibody 2, antibody HSL 96, antibody HSL 11, anti-human / c chain antibody, and anti-human chain antibody.</span>
  </div>
  <div id="p0035" num="0035" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 3 C図は、 ヒト I gM (ヒト〃鎖およびヒト λ鎖） に対する本発明の HSL 2抗体および HSL96抗体、 HSL 11抗体、 抗ヒト 鎖抗体ならびに抗ヒト λ鎖抗体のそれぞれの EL I S Αの結果を示す図である。 </span>&nbsp;FIG. 3C shows the respective ELISAs of HSL2 antibody and HSL96 antibody, HSL11 antibody, anti-human chain antibody and anti-human λ chain antibody of the present invention against human IgM (human 〃 chain and human λ chain). It is a figure showing a result.</span>
  </div>
  <div id="p0036" num="0036" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 4図は、 第 4 A図〜第 4H図の配置を示す図である。 </span>&nbsp;FIG. 4 is a diagram showing the arrangement of FIGS. 4A to 4H.</span>
  </div>
  <div id="p0037" num="0037" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 4A図は、 HSL2抗体 （抗プレ BCR) により、 プロ B細胞 （RS4;11) の細 胞表面を免疫染色して F AC Sで測定した結果を示す図である。 </span>&nbsp;FIG. 4A is a diagram showing the results of immunostaining of the cell surface of pro-B cells (RS4; 11) with an HSL2 antibody (anti-pre-BCR) and measurement by FACS.</span>
  </div>
  <div id="p0038" num="0038" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 4B図は、 HSL96抗体 (抗 VpreB)により、 プロ B細胞の細胞表面を免疫染 色して F A C Sで測定した結果を示す図である。 </span>&nbsp;FIG. 4B is a diagram showing the results of immunostaining of the cell surface of pro-B cells with the HSL96 antibody (anti-VpreB) and measurement by FACS.</span>
  </div>
  <div id="p0039" num="0039" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 4C図は、 HSL2抗体により、 プレ B細胞 （697) の細胞表面を免疫染 色して F AC Sで測定した結果を示す図である。 </span>&nbsp;FIG. 4C shows the results of immunostaining of the cell surface of pre-B cells (697) with the HSL2 antibody and measurement by FACS.</span>
  </div>
  <div id="p0040" num="0040" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 4D図は、 HSL96抗体により、 プレ B細胞の細胞表面を免疫染色して F ACSで測定した結果を示す図である。 </span>&nbsp;FIG. 4D shows the results of immunostaining of the cell surface of pre-B cells with the HSL96 antibody and measurement by FACS.</span>
  </div>
  <div id="p0041" num="0041" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 4E図は、 HSL2抗体により、 成熟 B細胞 （LBW— 4) の細胞表面を免疫染 色して F A C Sで測定した結果を示す図である。 </span>&nbsp;FIG. 4E is a diagram showing the results of immunostaining of the cell surface of mature B cells (LBW-4) with the HSL2 antibody and measurement by FACS.</span>
  </div>
  <div id="p0042" num="0042" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 4F図は、 HSL96抗体により、 成熟 B細胞の細胞表面を免疫染色して F ACSで測定した結果を示す図である。 </span>&nbsp;FIG. 4F is a diagram showing the results of immunostaining of the cell surface of mature B cells with the HSL96 antibody and measurement by FACS.</span>
  </div>
  <div id="p0043" num="0043" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 4G図は、 HSL2抗体により、 T細胞 (Jurkat)の細胞表面を免疫染色して F A C Sで測定した結果を示す図である。 </span>&nbsp;FIG. 4G is a diagram showing the results of immunostaining the cell surface of T cells (Jurkat) with the HSL2 antibody and measuring with FACS.</span>
  </div>
  <div id="p0044" num="0044" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 4H図は、 HSL96抗体により、 T細胞の細胞表面を免疫染色して F AC Sで測定した結果を示す図である。 </span>&nbsp;FIG. 4H is a diagram showing the results of immunostaining the cell surface of T cells with the HSL96 antibody and measuring with FACS.</span>
  </div>
  <div id="p0045" num="0045" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 5図は、 第 5 A図〜第 5 H図の配置を示す図である。 </span>&nbsp;FIG. 5 is a diagram showing the arrangement of FIGS. 5A to 5H.</span>
  </div>
  <div id="p0046" num="0046" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 5A図は、 HSL2抗体 （抗プレ BCR) により、 プロ B細胞 (RS4;11)の細 胞内を免疫染色して F A C Sで測定した結果を示す図である。 </span>&nbsp;FIG. 5A is a diagram showing the results of immunostaining of the cells of pro-B cells (RS4; 11) with the HSL2 antibody (anti-pre-BCR) and measurement by FACS.</span>
  </div>
  <div id="p0047" num="0047" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 5B図は、 HSL96抗体 （抗 VpreB) により、 プロ B細胞の細胞内を免疫染 

色して F ACSで測定した結果を示す図である。 </span>Fig. 5B shows immunostaining of pro-B cells with HSL96 antibody (anti-VpreB).  It is a figure which shows the result measured by FACS by coloring.</span>
  </div>
  <div id="p0048" num="0048" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 5 C図は、 HSL 2抗体により、 プレ B細胞 （697) の細胞内を免疫染色 して F ACSで測定した結果を示す図である。 </span>&nbsp;FIG. 5C shows the results of immunostaining of pre-B cells (697) with HSL2 antibody and measurement by FACS.</span>
  </div>
  <div id="p0049" num="0049" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 5D図は、 HS L 96抗体により、 プレ B細胞の細胞内を免疫染色して F A CSで測定した結果を示す図である。 </span>&nbsp;FIG. 5D is a diagram showing the results of immunostaining of pre-B cells with the HSL96 antibody and measurement by FACS.</span>
  </div>
  <div id="p0050" num="0050" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 5E図は、 HSL 2抗体により、 成熟 B細胞 (LBW-4)の細胞内を免疫染色して F A C Sで測定した結果を示す図である。 </span>&nbsp;FIG. 5E shows the results of immunostaining of mature B cells (LBW-4) with the HSL2 antibody and measurement with FACS.</span>
  </div>
  <div id="p0051" num="0051" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 5 F図は、 HS L 96抗体により、 成熟 B細胞の細胞内を免疫染色して F A C Sで測定した結果を示す図である。 </span>&nbsp;FIG. 5F is a diagram showing the results of immunostaining of mature B cells with the HSL96 antibody and measurement with FACS.</span>
  </div>
  <div id="p0052" num="0052" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 5 G図は、 HS L 2抗体により、 T細胞 (Jurkat)の細胞内を免疫染色して F</span>&nbsp;Fig. 5G shows the results of immunostaining of T cells (Jurkat) with HS L2 antibody.</span>
  </div>
  <div id="p0053" num="0053" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ACSで測定した結果を示す図である。 </span>It is a figure showing the result of having measured with ACS.</span>
  </div>
  <div id="p0054" num="0054" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 5H図は、 HS L 96抗体により、 T細胞の細胞表面を免疫染色して F AC Sで測定した結果を示す図である。 </span>&nbsp;FIG. 5H is a diagram showing the results of immunostaining of the cell surface of T cells with the HS L96 antibody and measurement by FACS.</span>
  </div>
  <div id="p0055" num="0055" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 6図は、 第 6 A図〜第 6 D図の配置を示す図である。 </span>&nbsp;FIG. 6 is a diagram showing the arrangement of FIGS. 6A to 6D.</span>
  </div>
  <div id="p0056" num="0056" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 6A図は、 HSL 2抗体 （抗プレ BCR) により、 ヒトぇ 5遺伝子を導入し た形質転換体 (X63/人 5 )を免疫染色して F AC Sで測定した結果を表す図であ o </span>&nbsp;FIG. 6A is a diagram showing the results of immunostaining of a transformant (X63 / person 5) transfected with the human ぇ 5 gene using an HSL2 antibody (anti-pre-BCR) and measurement by FACS.</span>
  </div>
  <div id="p0057" num="0057" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 6 B図は、 HS L 96抗体 （抗 VpreB) により、 ヒト人 5遺伝子を導入した 形質転換体を免疫染色して F A C Sで測定した結果を表す図である。 </span>&nbsp;FIG. 6B is a view showing the results of immunostaining of a transformant into which the human 5 gene was introduced using the HSL96 antibody (anti-VpreB) and measurement by FACS.</span>
  </div>
  <div id="p0058" num="0058" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 6 C図は、 本発明の HSL2抗体により、 ヒ卜 Vp r eB遺伝子を導入した 形質転換体 （X63/VpreB) を免疫染色して F A C Sで測定した結果を表す図であ る。 </span>&nbsp;FIG. 6C is a diagram showing the results of immunostaining of a transformant (X63 / VpreB) into which the human VprEB gene has been introduced with the HSL2 antibody of the present invention, followed by FACS measurement.</span>
  </div>
  <div id="p0059" num="0059" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 6D図は、 HSL96抗体により、 ヒト Vp r eB遺伝子を導入した形質転 換体を免疫染色して F A C Sで測定した結果を表す図である。 </span>&nbsp;FIG. 6D is a diagram showing the results of immunostaining of a transformant into which the human VpreB gene has been introduced with the HSL96 antibody and measurement by FACS.</span>
  </div>
  <div id="p0060" num="0060" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 7図は、 本発明の HSL 2抗体ならびに比較対照の HSL 96抗体、 HSL</span>&nbsp;FIG. 7 shows the HSL 2 antibody of the present invention and the HSL 96 antibody of the comparative control, HSL</span>
  </div>
  <div id="p0061" num="0061" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1 1抗体、 抗ヒト 鎖抗体およびマウス I A:により、 ヒトプレ B細胞およ 

びヒ卜プロ B細胞を免疫沈降して免疫沈降物を電気泳動した結果を表す電気泳動 写真である。 </span>11 Antibody, anti-human chain antibody and mouse IA:  4 is an electrophoretic photograph showing the results of immunoprecipitation of human and human pro-B cells and electrophoresis of the immunoprecipitate.</span>
  </div>
  <div id="p0062" num="0062" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 8図は、 本発明の HSL 2抗体ならびに比較対照の HSL 96抗体、 HSL</span>&nbsp;FIG. 8 shows the HSL 2 antibody of the present invention and the HSL 96 antibody of the comparative control, HSL</span>
  </div>
  <div id="p0063" num="0063" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">11抗体およびマウス I により、 ヒト人 5遺伝子を導入した形質転換体、 ヒト Vp re B遺伝子を導入した形質転換体およびヒトプレ B細胞を免疫沈降し て免疫沈降物を電気泳動した結果を表す電気泳動写真である。 </span>11 Electrophoresis showing the results of immunoprecipitation of the immunoprecipitate of the transformant transfected with the human 5 gene, the transfectant transfected with the human VpreB gene, and the human pre-B cells using the antibody and mouse I. It is a photograph.</span>
  </div>
  <div id="p0064" num="0064" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 9図は、 プレ B白血病細胞株 N a lm6またはプロ B白血病細胞株 RS4；</span>&nbsp;FIG. 9 shows the pre-B leukemia cell line Nalm6 or the pro-B leukemia cell line RS4;</span>
  </div>
  <div id="p0065" num="0065" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">11それぞれと H S L 2抗体と反応させて細胞内を免疫染色して F I T Cにより 発色させた結果を示す顕微鏡写真である。 </span>11 is a micrograph showing the result of immunostaining the inside of cells by reacting each of them with an HSL2 antibody and coloring the cells with FITC.</span>
  </div>
  <div id="p0066" num="0066" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 10図は、 プレ B白血病細胞株 Nalm6を HSL96抗体と反応させて細 胞内を免疫染色して F I TCにより発色させた結果を示す顕微鏡写真である。 第 11 A図は、 プロ B白血病細胞株 Na lm27を HSL 96抗体とサポニン 緩衝液を用いて反応させて細胞内を免疫染色して F I TCにより発色させた結果 を示す顕微鏡写真である （HSL 96抗体を反応させた結果） 。 </span>&nbsp;FIG. 10 is a micrograph showing the result of reacting the pre-B leukemia cell line Nalm6 with the HSL96 antibody, immunostaining the inside of the cells, and developing the cells by FITC. FIG. 11A is a photomicrograph showing the results of immunostaining of the cells by reacting the pro-B leukemia cell line Nalm27 with the HSL 96 antibody using a saponin buffer and developing the cells with FITC (HSL 96 Result of reacting antibody).</span>
  </div>
  <div id="p0067" num="0067" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 第 11 B図は、 プロ B白血病細胞株 Na lm27を HS L 96抗体とサポニン 緩衝液を用いて反応させて細胞内を免疫染色して F I TCにより発色させた結果 を示す顕微鏡写真である （対照としてマウス I gG! ATを反応させた結果） 。 発明を実施するための最良の形態 </span>&nbsp;FIG. 11B is a micrograph showing the result of immunostaining the inside of the cells by reacting the pro-B leukemia cell line Nalm27 with the HS L96 antibody using a saponin buffer and coloring with FITC (control As a result of reacting mouse IgG! AT). BEST MODE FOR CARRYING OUT THE INVENTION</span>
  </div>
  <div id="p0068" num="0068" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 1. 抗体の活性フラグメント </span>&nbsp;1. Active fragment of an antibody</span>
  </div>
  <div id="p0069" num="0069" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 本発明においては、 抗体は活性フラグメントをも包含するものである。 活性フ ラグメントとは、 抗原抗体反応活性を有する抗体のフラグメントを意味し、 具体 的には、 F (ab' ) <sub class="style-scope patent-text">2</sub> 、 Fab' 、 Fab、 F vなどを挙げることができる。 例えば、 本発明の抗体をペプシンで分解すると F (ab， ) <sub class="style-scope patent-text">2</sub> が得られ、 パ パインで分解すると F abが得られる。 F (ab， ) <sub class="style-scope patent-text">2</sub> を 2—メルカプトエタ ノールなどの試薬で還元して、 モノョード酢酸でアルキル化すると Fa b， が得 られる。 Fvは重鎖可変領域と軽鎖可変領域とをリンカーで結合させた一価の抗 

体活性フラグメントである。 </span>In the present invention, antibodies also include active fragments. The active fragment means a fragment of an antibody having an antigen-antibody reaction activity, and specific examples include F (ab ') <sub class="style-scope patent-text">2</sub> , Fab', Fab, Fv and the like. For example, when the antibody of the present invention is digested with pepsin, F (ab,) <sub class="style-scope patent-text">2</sub> is obtained, and when digested with papain, F ab is obtained. Reduction of F (ab,) <sub class="style-scope patent-text">2</sub> with a reagent such as 2-mercaptoethanol and alkylation with monoodoacetic acid gives Fa b,. Fv is a monovalent antibody with a heavy chain variable region and a light chain variable region  It is a body active fragment.</span>
  </div>
  <div id="p0070" num="0070" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> これらの活性フラグメン卜を保持し、 その他の部分を他の動物のフラグメント に置換することでキメラ抗体が得られる。 本明細書において、 「キメラ抗体」 と は、 可変領域または抗原結合ドメインと定常領域またはェフエクタ一ドメインと がそれぞれ遺伝的に異なった種に属する免疫グロプリン断片から構成されている 抗体である。 例えば、 マウスモノクローナル抗体の可変 （V)領域断片は、 ヒト 定常 （C)領域断片、 例えばァ 1またはァ 4と連結され得る。 </span>&nbsp;A chimeric antibody can be obtained by retaining these active fragments and substituting the other parts with fragments of another animal. As used herein, a “chimeric antibody” is an antibody in which the variable region or antigen-binding domain and the constant region or efector domain are each composed of an immunoglobulin fragment belonging to a genetically different species. For example, a variable (V) region fragment of a mouse monoclonal antibody can be ligated to a human constant (C) region fragment, eg, a1 or a4.</span>
  </div>
  <div id="p0071" num="0071" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 2. 遺伝子工学的な製法 </span>&nbsp;2. Genetic engineering</span>
  </div>
  <div id="p0072" num="0072" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 本発明の抗体は、 遺伝子工学的な方法を用いても得られる。 例えば、 プレ B細 胞レセプ夕一の//鎖と SL鎖の会合物質で免疫した動物の脾細胞、 リンパ球又は 本発明のモノクローナル抗体を産生するハイプリ ドーマから mRNAを採取し、 これをもとに cDNAライブラリーを作製する。 次に、 該 cDNAライブラリー により抗体を発現させる。 抗原と反応する抗体を産生するクローンをスクリー二 ングにより cDNAライブラリ一から得、 得られたクローンを培養し、 培養混合 物から目的とする抗体を、 塩析、 イオン交換クロマトグラフィー、 ァフィ二ティ —クロマトグラフィ一等の方法を組み合わせて精製することができる。 </span>&nbsp;The antibody of the present invention can also be obtained by using a genetic engineering method. For example, mRNA is collected from spleen cells, lymphocytes or a hybridoma that produces the monoclonal antibody of the present invention from an animal immunized with a substance that associates a pre-B cell receptor // chain with an SL chain and / or SL. Prepare a cDNA library. Next, an antibody is expressed using the cDNA library. A clone that produces an antibody that reacts with the antigen is obtained from the cDNA library by screening, the resulting clone is cultured, and the target antibody is extracted from the culture mixture by salting out, ion exchange chromatography, affinity, etc. Purification can be performed by a combination of methods such as chromatography.</span>
  </div>
  <div id="p0073" num="0073" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 3. 検出方法 </span>&nbsp;3. Detection method</span>
  </div>
  <div id="p0074" num="0074" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 本発明の抗体を用いたヒトプレ B細胞またはプレ B細胞レセプ夕一の検出は、 ELI SA法、 FACS法、 免疫沈降または顕微鏡観察のいずれにおいても可能 である。 </span>&nbsp;Detection of human pre-B cells or pre-B cell receptors using the antibody of the present invention can be performed by any of the ELISA method, FACS method, immunoprecipitation, or microscopic observation.</span>
  </div>
  <div id="p0075" num="0075" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 特に、 F ACS法または顕微鏡観察では、 細胞表面のプレ B細胞レセプ夕一や Vpr eB分子を検出するだけでなく、 抗体と検体を混合し、 反応させるときに サポニン緩衝液を用いることにより細胞内の Vp r eB分子をも染色して、 該分 子または該分子を内部に有する細胞を検出することができる。 </span>&nbsp;In particular, the FACS method or microscopic observation not only detects pre-B cell receptors and VpreB molecules on the cell surface, but also uses the saponin buffer solution when mixing and reacting the antibody with the sample and reacting them. The VpreB molecule can also be stained to detect the molecule or cells having the molecule therein.</span>
  </div>
  <div id="p0076" num="0076" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 4. ィムノ トキシンとしての使用 </span>&nbsp;4. Use as imnotoxin</span>
  </div>
  <div id="p0077" num="0077" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 抗体に毒素を結合させたィムノ トキシンを作製することは、 例えば、 Proc. 

 Nat l. Acad. Sc i. USA 87卷 （1990年） 8291— 829 5ページに記載の方法により可能である。 本発明の抗体にもこの方法を適用して 毒素を結合させィムノ トキシンを作製することが可能である。 このィムノ トキシ ンをプレ B細胞由来の白血病患者に投与することで、 患者体内で増殖したプレ B 細胞に選択的に毒素を作用させ、 該細胞を死滅させ、 該細胞由来の白血病を治療 することができる。 毒素としては、 ェキソトキシン、 ジフテリアトキシン等があ る。 </span>Producing imotoxins in which a toxin is conjugated to an antibody is described, for example, in Proc.  Natl. Acad. Sc i. USA Vol. 87 (1990) 8291-829. By applying this method to the antibody of the present invention, it is possible to bind a toxin to prepare an imnotoxin. By administering this imnotoxin to a pre-B cell-derived leukemia patient, the toxin selectively acts on the pre-B cells grown in the patient, killing the cells and treating leukemia derived from the cells. Can be. Examples of toxins include exotoxin and diphtheria toxin.</span>
  </div>
  <div id="p0078" num="0078" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 5. 複合物としての使用 </span>&nbsp;5. Use as a composite</span>
  </div>
  <div id="p0079" num="0079" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 本発明の抗体またはその活性フラグメントは、 単独でも用いられるが、 必要に 応じて、 アルブミン、 ポリエチレングリコール等の物質と結合させ、 新たな複合 物として用いることができる。 このような複合物は、 一般に、 生体内では、 長時 間分解されずにその効果を最大限まで発揮することが多い。 一般的には、 SPD P (シグマ社製または、 フアルマシア製） 等の 2価反応性試薬を用いれば、 活性 フラグメントをアルブミン等と容易に結合させることができる。 </span>&nbsp;The antibody or the active fragment thereof of the present invention can be used alone, but can be used as a new complex by binding to a substance such as albumin or polyethylene glycol if necessary. In general, such a complex is most likely to exhibit its effect in vivo without being decomposed for a long time. In general, the use of a bivalent reactive reagent such as SPD P (manufactured by Sigma or Pharmacia) allows the active fragment to be easily bound to albumin or the like.</span>
  </div>
  <div id="p0080" num="0080" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">実施例 </span>Example </span>
  </div>
  <div id="p0081" num="0081" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 以下に本発明の実施例を示し、 より具体的に本発明を説明するが、 本発明は 以下に限定されるものではなく、 免疫する動物、 対象とする細胞株、 標識抗体等 は、 目的に応じて適宜他のものが使用可能である。 </span>&nbsp;Hereinafter, the present invention will be described in more detail with reference to Examples of the present invention. However, the present invention is not limited to the following, and the immunized animal, target cell line, labeled antibody, etc. Others can be used as appropriate.</span>
  </div>
  <div id="p0082" num="0082" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> &lt;実施例 1 &gt;抗体の作製（1) </span>&nbsp;&lt;Example 1&gt; Preparation of antibody (1)</span>
  </div>
  <div id="p0083" num="0083" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 1. 抗原の作製 </span>&nbsp;1. Preparation of antigen</span>
  </div>
  <div id="p0084" num="0084" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 1 ) 抗原遺伝子組み換え体の作製 </span>&nbsp;1) Preparation of recombinant antigen</span>
  </div>
  <div id="p0085" num="0085" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> (1) 人 5遺伝子および Vp re B遺伝子の作製 </span>&nbsp;(1) Preparation of 5 human genes and Vpre B gene</span>
  </div>
  <div id="p0086" num="0086" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ヒト人 5遺伝子およびヒト Vp r e B遺伝子は、 ヒトプレ B細胞 N a lm6か ら常法により mRNAを調製し、 該 mRNAについて、 下記のプライマーで RT —PCR法を行うことにより作製した。 作製した mRNAについてそれぞれシー クエンスを行い、 ヒト λ 5およびヒト Vp r eB遺伝子の塩基配列を有すること 

を確認した。 </span>The human 5 gene and the human Vpre B gene were prepared by preparing mRNA from human pre-B cells Nalm6 by a conventional method and subjecting the mRNA to RT-PCR using the following primers. Sequence each of the prepared mRNAs and have the nucleotide sequences of human λ5 and human VpreB genes.  It was confirmed.</span>
  </div>
  <div id="p0087" num="0087" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> λ 5プライマ </span>&nbsp;λ 5 primer</span>
  </div>
  <div id="p0088" num="0088" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 5 ' プライマ 5，-GGA ACT CGA GCC ACA AGG ACC TCT GAC CCT - 3， 3' プライマ 5，-GGA AGC GGC CGC AGG CCT TTG GGT GGG GTC GG-3' Vp r eBプライマ </span>&nbsp;5 'primer 5, -GGA ACT CGA GCC ACA AGG ACC TCT GAC CCT-3, 3' primer 5, -GGA AGC GGC CGC AGG CCT TTG GGT GGG GTC GG-3 'Vp r eB primer</span>
  </div>
  <div id="p0089" num="0089" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 5 ' プライマー 5，-GGA ACT CGA GGG AGT CAG AGC TCT GCA TGT-3' 3' プライマー 5，-GGA AGC GGC CGC AGG GGA TGC GTG CCT CTG CT-3<sup class="style-scope patent-text">5</sup> </span>5 'primer 5, -GGA ACT CGA GGG AGT CAG AGC TCT GCA TGT-3' 3 'primer 5, -GGA AGC GGC CGC AGG GGA TGC GTG CCT CTG CT-3 <sup class="style-scope patent-text">5</sup> </span>
  </div>
  <div id="p0090" num="0090" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(2) ベクタ一への挿入 </span>(2) Insertion into vector</span>
  </div>
  <div id="p0091" num="0091" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> サイ トメガロウィルスのプロモ一夕一とィムノグロプリンの 鎖のェンハンサ —をもつ哺乳類動物用の発現べクタ一 BCMGSHyg (この製法については、 J. Exp. Med. 172卷、 969— 972ページに記載の方法に従った。 ) に、 （ 1) で作製した人 5遺伝子および Vp r eB遺伝子を常法により挿入し </span>&nbsp;BCMGSHyg, an expression vector for mammals with the cytomegalovirus promoter overnight and the immunoglobulin chain enhancer (see the method described in J. Exp. Med. Vol. 172, p. 969-972). Then, the human 5 gene and the VprEB gene prepared in (1) were inserted by a conventional method.</span>
  </div>
  <div id="p0092" num="0092" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">( 3 ) 形質転換体の作製 </span>(3) Preparation of transformant</span>
  </div>
  <div id="p0093" num="0093" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> マウス〃鎖を発現する宿主 L t k— (マウス 鎖） に、 （2) で作製した ぺク夕一を、 エレクトロポーレーション法により導入し（この方法については、 J. Exp. Med. 1 72卷、 969— 972ページを参照のこと）、 キメラ のブレ B細胞レセプ夕一 （マウス 鎖/ヒト人 5/ヒト Vp r eB) を発現およ び分泌する形質転換体 L t k一 （マウス〃鎖/ヒト人 5/ヒト Vp r e B) を作製した。 </span>&nbsp;To the mouse Ltk- (mouse chain) expressing the mouse 〃 chain, the vector prepared in (2) was introduced by electroporation (see J. Exp. Med. 969-972), a transformant Ltk-1 (mouse 〃 / expressing and secreting the chimeric Ble receptor B-1 (mouse chain / human 5 / human VprEB). Human 5 / human Vpre B) was prepared.</span>
  </div>
  <div id="p0094" num="0094" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ( ) 形質転換体の選別 </span>&nbsp;() Selection of transformants</span>
  </div>
  <div id="p0095" num="0095" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ①形質転換体 L t k— (マウス//鎖/ヒト人 5/ヒト Vp r eB) を、 0. 2mg/mlのハイグロマイシンと G4 18を含む 10%FCS— RPMI 16 40を培地として、 96穴プレートで、 37°C、 5%C02下で培養した。 </span>&nbsp;(1) Transformant L tk— (mouse // chain / human 5 / human VprEB) was used as a medium with 10% FCS containing 0.2 mg / ml of hygromycin and G418—RPMI 1640 as a medium. The plate was cultured at 37 ° C under 5% C02.</span>
  </div>
  <div id="p0096" num="0096" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ②培養上清を下記の条件 1の EL I SA法により測定した。 1200ゥエル 中、 約 600ゥエルにコロニーが発現し、 そのうち 405 nmでの吸光度の高い 

 16ゥエルを陽性として選択した。 </span>(2) The culture supernatant was measured by the ELISA method under the following condition 1. Colonies develop at approximately 600 μl out of 1200 μl, of which high absorbance at 405 nm  16 μl was selected as positive.</span>
  </div>
  <div id="p0097" num="0097" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> EL I S A条件 1 </span>&nbsp;EL I S A condition 1</span>
  </div>
  <div id="p0098" num="0098" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 96穴プレー卜のコーティング：ャギ抗マウス I gM ( 10 z /ml) で コ一ティングした。 </span>&nbsp;Coating of 96-well plate: Coated with goat anti-mouse IgM (10 z / ml).</span>
  </div>
  <div id="p0099" num="0099" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 試料：形質転換体 Ltk一 （マウス/鎖/ヒ ト人 5/ヒト VpreB) の 培養上清 </span>&nbsp;Sample: culture supernatant of transformant Ltk-1 (mouse / chain / human 5 / human VpreB)</span>
  </div>
  <div id="p0100" num="0100" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 検出用抗体：アル力リフォスファターゼ標識ャギ抗マウス I gM (サザンバ ィォテクノロジ一ァソシエイヅ （Southern Biot echno log y As s o c i a t e s)社製を 300倍希釈） </span>&nbsp;Antibody for detection: Alkaline phosphatase-labeled goat anti-mouse IgM (300-fold dilution from Southern Biotechnology, Inc. (Southern Biotechnology, Inc.))</span>
  </div>
  <div id="p0101" num="0101" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 基質： PNPP (p—二トロフエニルフォスフェート、 シグマ社製）</span>&nbsp;Substrate: PNPP (p-ditrophenyl phosphate, manufactured by Sigma)</span>
  </div>
  <div id="p0102" num="0102" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">③②の E L I SAを数回繰り返し、 さらに、 陽性株については、 限界希釈法を 用いてクロ一ン化し、 プレ B細胞レセプ夕一 （マウス 鎖/ヒト λ 5/ヒト Vp r eB) を高発現する陽性株を選択した。 該陽性株を L t k一 17— 72と 名付けた。 </span>③ Repeat ELI SA several times, and clone the positive strain using limiting dilution method to highly express pre-B cell receptor (mouse chain / human λ5 / human VpreB) Positive strains were selected. The positive strain was named Ltk 17-72.</span>
  </div>
  <div id="p0103" num="0103" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 2)抗原蛋白質の大量培養 </span>&nbsp;2) Mass culture of antigen protein</span>
  </div>
  <div id="p0104" num="0104" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 上記でとった形質転換体 L t k一 17— 72を、 5%FCS— RPMI 1 640培地で、 複数の 1 L容ローラボトルにて 37°Cで培養した。 1本のローラ ボトルに 200mlの培地を注入して、 2週間培養した。 2週間の培養後、 培地 中のプレ B細胞レセプ夕一 （マウス〃鎖/ヒト人 5/ヒト Vp r eB) の濃度を 上記と同様に EL I S A条件 1により測定した結果、 約 5ng/mlの濃度であ つた。 </span>&nbsp;The transformants Ltk-17-72 obtained above were cultured in 5% FCS-RPMI1640 medium at 37 ° C in a plurality of 1L roller bottles. 200 ml of the medium was injected into one roller bottle and cultured for 2 weeks. After culturing for 2 weeks, the concentration of pre-B cell receptor (mouse 〃 chain / human 5 / human VprEB) in the medium was measured under the same ELISA conditions 1 as described above. It was the concentration.</span>
  </div>
  <div id="p0105" num="0105" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 3)抗原の精製 </span>&nbsp;3) Purification of antigen</span>
  </div>
  <div id="p0106" num="0106" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> (1)濃縮 </span>&nbsp;(1) Concentration</span>
  </div>
  <div id="p0107" num="0107" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 2) の培養上清 2 Lを集め、 濃縮装置 （MINI TAN (登録商標、 ミリポア 社製） ） を使用して約 10倍に濃縮した。 </span>&nbsp;2 L of the culture supernatant obtained in 2) was collected and concentrated approximately 10-fold using a concentrator (MINI TAN (registered trademark, manufactured by Millipore)).</span>
  </div>
  <div id="p0108" num="0108" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> (2)精製 

 ①ビーズ （CNB r活性化セファロ一ス 4B、 フアルマシア社製） にラット抗 マウス//鎖抗体を常法により付け、 カラムに充填した。 </span>(2) Purification  (1) A rat anti-mouse // chain antibody was attached to beads (CNB r-activated Sepharose 4B, manufactured by Pharmacia) in a conventional manner, and the column was packed.</span>
  </div>
  <div id="p0109" num="0109" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ②このカラムに濃縮した培養上清を 2週間循環させて通し、 培養上清中のプ レ B細胞レセプ夕一 （マウス//鎖/ヒト人 5/ヒト Vpr eB) を抗原蛋白質と してビーズに結合させた抗原—ビーズ結合体を作製した。 </span>&nbsp;(2) The concentrated culture supernatant is circulated through this column for 2 weeks, and the pre-B cell receptor in the culture supernatant (mouse // chain / human 5 / human VpreB) is used as an antigen protein and beads. To prepare an antigen-bead conjugate.</span>
  </div>
  <div id="p0110" num="0110" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 合計で約 20 Lの培養上清について上記の濃縮および精製を行い抗原蛋白質 50〃gを 500 1の抗原ビーズに結合させた抗原蛋白質一ビーズ結合体を作 製した （培地中の抗原蛋白質の回収率は 50%であった。 ） 。 </span>&nbsp;The above-mentioned concentration and purification were performed on a total of about 20 L of the culture supernatant to prepare an antigen-protein-bead conjugate in which 50 μg of the antigen protein was bound to 5001 antigen beads (recovery of the antigen protein in the medium). The rate was 50%.</span>
  </div>
  <div id="p0111" num="0111" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 2. 免疫 </span>&nbsp;2. Immunity</span>
  </div>
  <div id="p0112" num="0112" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 上記で作製した抗原蛋白質—ビーズ結合体をメスの B A LB/cマウスの四肢 付け根皮下に、 1匹あたり 1 g/l 0〃1のビーズを免疫した。 2回目以降の 免疫には、 抗原蛋白質一ビーズ結合体を PB Sの懸濁液にして、 1匹あたり 1 g/10〃 1のビーズを 7日おきに合計 7回免疫した。 その後、 8週間おいてか ら抗原蛋白質一ビーズ結合体より溶出させた抗原蛋白質溶液 （抗原蛋白質量 30 .s) を尾より静注して追加免疫した。 </span>&nbsp;The antigen protein-bead conjugate prepared above was immunized subcutaneously at the base of the extremity of a female BALB / c mouse with 1 g / l 0/1 beads per animal. For the second and subsequent immunizations, the antigen protein-one bead conjugate was used as a suspension in PBS, and 1 g / 10〃1 beads per animal were immunized every seven days for a total of seven immunizations. After 8 weeks, the antigen protein solution eluted from the antigen protein-bead conjugate (antigen protein mass: 30 .s) was injected intravenously via the tail to perform additional immunization.</span>
  </div>
  <div id="p0113" num="0113" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 前記抗原蛋白質溶液 （抗原蛋白質一ビーズ結合体を 0. 1Mグリシン （pH2. 7) で溶出した液） の SD S— PAGE電気泳動の結果を図 1に示す。 電気泳動 の結果、 〃鎖、 人 5、 Vp r eBのバンドが見られ抗原蛋白質がこれらからなる 分泌型プレ B細胞レセプ夕一 （マウス〃鎖/ヒト λ 5/ヒト Vp r eB) である ことが確認された。 </span>&nbsp;FIG. 1 shows the results of SDS-PAGE electrophoresis of the antigen protein solution (a solution obtained by eluting the antigen protein-bead conjugate with 0.1 M glycine (pH 2.7)). As a result of electrophoresis, bands of 〃 chain, human 5, VpreB are observed, and the antigen protein is secretory pre-B cell receptor consisting of these (mouse 〃 chain / human λ5 / human VpreB). Was confirmed.</span>
  </div>
  <div id="p0114" num="0114" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 3. モノクローナル抗体の作製 </span>&nbsp;3. Preparation of monoclonal antibody</span>
  </div>
  <div id="p0115" num="0115" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 1) ハイプリ ドーマの作製 </span>&nbsp;1) Production of Hypri-Dorma</span>
  </div>
  <div id="p0116" num="0116" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 追加免疫 3日後に、 免疫したマウスの脾臓から脾細胞 2. 2 108 個を 取り出し、 マウスミエ口一マ細胞 P A Iと 4 ： 1の割合でポリエチレングリコ一 ル （ベ一リンガー社製） 細胞融合した。 こうして得られたハイプリ ドーマを 96 穴プレート 10枚にまき、 100倍希釈の HAT (ベ一リンガー社製） と 500 

倍希釈の I L一 6 (形質転換体 X63BCMGNe o (この製法については J. EXp. Me d. 171巻、 389— 400ページを参照のこと） の培養上清） を加えた 20%FCS— IMDM (ギブコ社製） で培養した。 </span>Three days after the booster immunization, 2.2 108 spleen cells were removed from the spleen of the immunized mouse, and fused with polyethylene glycol (Bellinger) cells at a ratio of 4: 1 with mouse myeoma cell line PAI. The obtained Hypri-Doma is spread on 10 96-well plates, and a 100-fold diluted HAT (manufactured by Behringer) and 500  20% FCS-IMDM (double-diluted IL-16) (culture supernatant of transformant X63BCMGNeo (for the preparation method, refer to J. EXp. Med., Vol. 171; pages 389-400)) was added. (Manufactured by Gibco).</span>
  </div>
  <div id="p0117" num="0117" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 2) スクリーニング </span>&nbsp;2) Screening</span>
  </div>
  <div id="p0118" num="0118" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ( 1) EL I SA </span>&nbsp;(1) EL I SA</span>
  </div>
  <div id="p0119" num="0119" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 約 2週間、 ハイプリ ドーマを培養した。 960ゥエル （プレート 10枚） 中、 約 260ゥエルにコロニーが発現した。 コロニーをつくったハイプリ ドーマの培 養上清を、 下記の条件 2の EL I SA法で測定した。 </span>&nbsp;The hybridoma was cultured for about 2 weeks. Colonies appeared in about 260 ゥ of 960 ゥ (10 plates). The culture supernatant of the hybridoma that formed the colonies was measured by the ELISA method under the following condition 2.</span>
  </div>
  <div id="p0120" num="0120" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> EL I S A条件 2 </span>&nbsp;EL I S A condition 2</span>
  </div>
  <div id="p0121" num="0121" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ① 96穴プレートのコ一ティング：以下の 4種類の抗体を 9 6穴プレートに それぞれコ一ティングした。 コーティングに用いた各抗体は、 10〃g/mlの 濃度のものを用い、 ブレー卜の各ゥヱルに 50 1ずつ加え、 4°Cでー晚静置し た。 その後、 0. 05% t we e n 20— PB Sで洗浄した後、 4%BSA—0. 2%twe en20— P B Sをブロッキング液として 200 / 1ずつ各ゥエルに 加え、 4 Cで一時間静置した。 </span>&nbsp;(1) Coating of 96-well plate: The following four types of antibodies were coated on a 96-well plate, respectively. Each antibody used for coating was used at a concentration of 10 μg / ml, and 50 1 was added to each plate of the plate, and the plate was allowed to stand at 4 ° C. Then, after washing with 0.05% tween 20-PBS, add 4% BSA-0.2% tween20-PBS as a blocking solution to each well at 200/1 each and leave at 4 C for 1 hour did.</span>
  </div>
  <div id="p0122" num="0122" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A：ャギ抗マウス 鎖抗体 （サザンバイオテクノロジ一ァソシェイツ社製） で コーティングしてブロッキングした後、 L t k— 1 7— 72の培養上清の 1 0倍濃縮液をコーティングした。 </span>&nbsp;A: After coating with a goat anti-mouse chain antibody (Southern Biotechnology Inc.) and blocking, a 10-fold concentrated solution of the culture supernatant of Ltk-17-72 was coated.</span>
  </div>
  <div id="p0123" num="0123" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> B ：ャギ抗マウス〃鎖抗体 （同上） でコ一ティングした。 </span>&nbsp;B: Coated with goat anti-mouse II chain antibody (Id.).</span>
  </div>
  <div id="p0124" num="0124" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> C ： ヒト I gM (〃鎖およびえ鎖） （サザンバイオテクノロジ一ァソシエイヅ 社製） でコーティングした。 </span>&nbsp;C: Coated with human IgM (〃 chain and e chain) (manufactured by Southern Biotechnology, Inc.).</span>
  </div>
  <div id="p0125" num="0125" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> D : ヒト I gM (〃鎖および 鎖） （サザンバイオテクノロジーァソシェイツ 社製） でコーティングした。 </span>&nbsp;D: Coated with human IgM (〃 chain and chain) (Southern Biotechnology Associates).</span>
  </div>
  <div id="p0126" num="0126" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ②抗原抗体反応：各プレートを 0. 05%twe en20— PBSで洗浄した 後、 各ゥヱルに 4%B S A— 0. 2%t we en20— PBSを希釈液として 3 0 1ずつ各ゥエルに加え、 さらに上記のハイプリ ドーマの培養上清を 3 Oj l 

ずつ各ゥエルに加えて混合し、 室温で 2時間静置し抗原抗体反応させた。 </span>(2) Antigen-antibody reaction: After washing each plate with 0.05% Tween 20-PBS, add 3% of 4% BSA-0.2% Tween 20-PBS as a diluent to each well in each well. Furthermore, the culture supernatant of the above hybridoma was added to 3 Ojl  Each well was added to each well, mixed, and allowed to stand at room temperature for 2 hours for antigen-antibody reaction.</span>
  </div>
  <div id="p0127" num="0127" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ③呈色反応：抗原抗体反応後、 各プレートを 0. 05%tween20— PB Sで洗浄した後、 アルカリフォスファタ一ゼ標識ャギ抗マウス I gG抗体 （サザ ンバイオテクノロジ一社製を 500倍希釈） を検出用抗体として 100 /1ずつ 各ゥヱルに加え、 室温で 1時間静置した。 その後、 各プレートを 0. 05%tw een20— PB Sで洗浄した後、 PNPPを基質として各ゥエルに 100 1 ずつ加え、 室温で 30分間静置して、 呈色させた。 </span>&nbsp;③ Color reaction: After the antigen-antibody reaction, wash each plate with 0.05% tween20-PBS, then use alkaline phosphatase-labeled goat anti-mouse IgG antibody (500 times higher than that of Susan Biotechnology Inc.) (Dilution) was added as a detection antibody at a ratio of 100/1 to each gel, and left at room temperature for 1 hour. Then, each plate was washed with 0.05% Tween20-PBS, 1001 was added to each well using PNPP as a substrate, and the plate was allowed to stand at room temperature for 30 minutes to be colored.</span>
  </div>
  <div id="p0128" num="0128" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ④その後、 405 rimにおける吸光度を測定した。 </span>&nbsp;④ Thereafter, the absorbance at 405 rim was measured.</span>
  </div>
  <div id="p0129" num="0129" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 405 nmにおける吸光度が高くなるものを陽性とし、 Aのコ一ティングで 陽性となり、 B、 Cおよび Dのコーティングで陰性となる培養上清を産生するハ イブリ ドーマを選択した。 その結果、 コロニ一を作った 260ゥエルのハイプリ ドーマのうち 14ゥエルのハイブリ ドーマが選択された。 </span>&nbsp;Hybridomas producing a culture supernatant which became positive when the absorbance at 405 nm increased and became positive by coating A and became negative by coating B, C and D were selected. As a result, a 14 ゥ -ell hybridoma was selected from the 260 ゥ -ell hybrid dome that created the colony.</span>
  </div>
  <div id="p0130" num="0130" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ( 2 ) 細胞表面染色 </span>&nbsp;(2) Cell surface staining</span>
  </div>
  <div id="p0131" num="0131" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 上記で陽性株として選んだハイプリ ドーマ 14クローンから、 ヒトプレ B白血 病細胞株 N a lm6の細胞表面に発現しているプレ B細胞レセプターとの反応が 陽性となるクローンを選択するために、 細胞表面染色を行った。 </span>&nbsp;From the 14 positive hybridoma clones selected above as positive strains, select the clones that are positive for the reaction with the pre-B cell receptor expressed on the cell surface of the human pre-B leukemia cell line Nalm6. Staining was performed.</span>
  </div>
  <div id="p0132" num="0132" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 具体的には、 96ゥェルプレートの各ゥエルに 1 X 10<sup class="style-scope patent-text">6</sup> 個の Nalm6 細胞を入れ、 それぞれに各クローンの培養上清を 50 1加え、 室温で 30分間 反応させた。 その後、 二次抗体として、 PE標識ャギ抗マウス 鎖抗体 （2〃g /ml) を 100〃 1各ゥエルに加えた。 </span>Specifically, 1 × 10 <sup class="style-scope patent-text">6</sup> Nalm6 cells were placed in each well of a 96-well plate, and 50 1 of the culture supernatant of each clone was added to each well, followed by reaction at room temperature for 30 minutes. Thereafter, as a secondary antibody, PE-labeled goat anti-mouse chain antibody (2 μg / ml) was added to each 100 μl of each well.</span>
  </div>
  <div id="p0133" num="0133" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> この試料を、 ファックスキヤリバ一 （FACS Cal ibur、 べクトン デヅキンソン社製） にて測定した。 </span>&nbsp;This sample was measured with a FAX scanner (FACS Cal ibur, manufactured by Becton Dickinson).</span>
  </div>
  <div id="p0134" num="0134" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 交差反応性の対象として、 成熟 B細胞 Daud i、 LBW—4についても同 様に細胞表面染色して F ACS Ca 1 iburにて測定した。 </span>&nbsp;As a cross-reactivity target, mature B cells Daud i and LBW-4 were similarly stained on the cell surface and measured with FACS Ca1 ibur.</span>
  </div>
  <div id="p0135" num="0135" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> その結果、 14クローン中、 4クローンが Na lm6で陽性となり、 Daud iおよび LB W— 4で陰性となった。 

 ( 3 ) 免疫沈降 </span>As a result, of the 14 clones, 4 clones were positive for Nalm6 and negative for Daudi and LBW-4.  (3) Immunoprecipitation</span>
  </div>
  <div id="p0136" num="0136" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 上記 4クローンの培養上清 lmlをプロテイン Gセファロ一ス （フアルマシア 社製） 20〃1と （50%V/V) と 4°Cで一晩混合した。 </span>&nbsp;Lml of the culture supernatant of the above 4 clones was mixed with Protein G Sepharose (Pharmacia) 20〃1 and (50% V / V) at 4 ° C overnight.</span>
  </div>
  <div id="p0137" num="0137" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> この混合液を 10000 r pmで 5分間遠心分離して抗体が結合したプロティ ン Gセファロ一スを取り分けた。 </span>&nbsp;This mixture was centrifuged at 10,000 rpm for 5 minutes to separate out the antibody-bound Protein G Sepharose.</span>
  </div>
  <div id="p0138" num="0138" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 該プロテイン Gセファロ一スを溶解液 （ 1%NP— 40、 15 OmM NaC 1) で洗浄した。 </span>&nbsp;The protein G Sepharose was washed with a lysis solution (1% NP-40, 15 OmM NaCl).</span>
  </div>
  <div id="p0139" num="0139" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> アイソトープ 35 sメチォニン ·システィンで内部標識したプレ B細胞 Na 11116を 1 105 個と溶解液 （ 1 %NP— 40、 150 mM N a C 1 ) とを混合し細胞溶解液を得た。 </span>&nbsp;A cell lysate was obtained by mixing 1105 pre-B cell Na 11116 internally labeled with 35 s methionine cysteine isotope and a lysate (1% NP-40, 150 mM NaC 1).</span>
  </div>
  <div id="p0140" num="0140" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 抗体結合プロテイン Gセファロースを細胞溶解液に懸濁し、 2時間混合した。 この混合液を 10000 r pmで 5分間遠心分離して免疫沈降物 （上記プロテ イン Gセファロ一スに結合した N a lm6由来の蛋白質） を取り分けた。 </span>&nbsp;Antibody-bound protein G Sepharose was suspended in the cell lysate and mixed for 2 hours. This mixture was centrifuged at 10,000 rpm for 5 minutes to separate immunoprecipitates (Nalm6-derived proteins bound to the protein G Sepharose).</span>
  </div>
  <div id="p0141" num="0141" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 免疫沈降物を洗浄液 （ 1 %NP— 40、 65 OmM NaCl)約 lmlで洗 浄することを 4回繰り返し、 電気泳動用の試料とした。 </span>&nbsp;Washing of the immunoprecipitate with about 1 ml of a washing solution (1% NP-40, 65 OmM NaCl) was repeated four times to obtain a sample for electrophoresis.</span>
  </div>
  <div id="p0142" num="0142" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 免疫沈降物を 2—メルカプトェ夕ノ一ル存在下で 95 °Cで 5分間還元した後、 13%ァクリルアミ ドゲルに展開した。 プレ B細胞レセプ夕一 （ヒト ヒト入 5/ヒト Vp r eB) の 3バンドが確認できたのは、 4クローンのうち 1クロー ンであった。 該クローンの電気泳動の結果を図 2に示す。 対照には、 マウス I g Gを含む培養上清 （コントロール） および抗ヒト 鎖抗体を含む培養上清を用い た。 </span>&nbsp;The immunoprecipitate was reduced in the presence of 2-mercaptoyl at 95 ° C for 5 minutes and then developed on a 13% acrylamide gel. Three bands of pre-B cell receptor Yuichi (human / human 5 / human VprEB) were confirmed in 1 out of 4 clones. FIG. 2 shows the results of electrophoresis of the clone. As controls, a culture supernatant containing mouse IgG (control) and a culture supernatant containing anti-human chain antibody were used.</span>
  </div>
  <div id="p0143" num="0143" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 3) クロ一ニング </span>&nbsp;3) Cloning</span>
  </div>
  <div id="p0144" num="0144" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 上記最終的に残った 1クローンのハイプリ ドーマを限界希釈法により、 96穴 プレートに 1細胞/ゥエルとなるように撒いた後、 10日間培養した。 1コロニ —/ゥエルとなったコロニーを 10個選択し、 E L I S A条件 2にて E L I SA 法により、 Aのコーティングでの吸光度を測定した。 最も吸光度が高くなつたハ 

イブリ ドーマを HSL 96と名付け、 該ハイプリ ドーマを工業技術院生命工学ェ 業技術研究所に 1997年 5月 30日に寄託した （受託番号 FERM P— 16 251) 。 該ハイプリ ドーマを国際寄託機関である同研究所において 1998年 5月 2 5日にブ夕ぺスト条約に基づく寄託へ移管した。 受託番号 FERM BP-6375o な お、 ハイプリ ドーマ HSL 96が産生する抗体を HSL 96抗体と呼ぶ。 </span>One clone of the hybrididoma finally remaining was spread on a 96-well plate at 1 cell / well by limiting dilution, and then cultured for 10 days. Ten colonies with 1 colony / ゥ / well were selected, and the absorbance at the coating of A was measured by ELISA under ELISA condition 2. C with the highest absorbance  The Ibri domestica was named HSL 96, and the Hypri doma was deposited with the Institute of Biotechnology and Industrial Technology of the National Institute of Advanced Industrial Science and Technology on May 30, 1997 (accession number FERM P-16251). The Hypri-Doma was transferred to the International Depositary Research Institute on May 25, 1998, to deposit under the Bush Treaty. The antibody produced by hybridoma HSL 96, such as Accession No. FERM BP-6375o, is referred to as HSL 96 antibody.</span>
  </div>
  <div id="p0145" num="0145" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 4. モノクローナル抗体の大量生産 </span>&nbsp;4. Mass production of monoclonal antibodies</span>
  </div>
  <div id="p0146" num="0146" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 生後 7週目の I CRnu/nu マウス （チヤ一ルス ' リーバ社製） の腹腔に プリスタン 0. 5mlを注入し、 その 5日後に、 各マウスにハイプリ ドーマ HS 96を1 10<sup class="style-scope patent-text">7</sup> 個注入した。 約 2週間後、 腹水を回収し、 力プリル酸法 （ Ant ibodies A Laborat ory Manual 8章、 30 0ぺ一ジ、 1988年 Co ld Spring Harbor Labora t ory出版、 に記載の方法） にしたがって精製し、 モノクローナル抗体を得た。 モノクローナルマウス I gアイソ夕ィビングキッ ト （ファーミンジェン社製） を 用いて該抗体のサブクラスが I gGi cであることを確認した。 </span>Pristane 0. 5 ml were injected into the peritoneal cavity of postnatal 7 week I CRnu / nu mice (Chiya manufactured one pulse 'Reva), that after 5 days, the High Priestess dormer HS 96 was 1 10 <sup class="style-scope patent-text">7</sup> injected into each mouse. Approximately two weeks later, ascites was collected and purified according to the force prillic acid method (the method described in Antibodies A Laboratory Manual, Chapter 8, 300 Pages, 1988, Cold Spring Harbor Laboratory Publishing). A monoclonal antibody was obtained. Using a monoclonal mouse Ig isoving kit (Pharmingen), it was confirmed that the subclass of the antibody was IgGGic.</span>
  </div>
  <div id="p0147" num="0147" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> &lt;実施例 2〉抗体の作製 (2) </span>&nbsp;&lt;Example 2&gt; Preparation of antibody (2)</span>
  </div>
  <div id="p0148" num="0148" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 実施例 1と同様にして、 ヒトプレ B細胞レセプ夕一を認識する別のモノクロ一 ナル抗体を作製した。 </span>&nbsp;In the same manner as in Example 1, another monoclonal antibody recognizing human pre-B cell receptor was prepared.</span>
  </div>
  <div id="p0149" num="0149" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ハイプリ ドーマの作製時のスクリーニングで E L I S Aに供したハイプリ ドー マ、 768ゥエル （プレート 8枚） 中、 約 600ゥエルにコロニーが発現した。 ELISAによるスクリーニングの結果、 コロニーを作った 600ゥエルのハイプリ ドーマのうち 2 8ゥエルのハイブリ ドーマが選択された。 </span>&nbsp;Colonies were expressed in approximately 600 μl out of 768 μl (8 plates) of the hybridomas subjected to ELISA in screening at the time of hybrididoma production. As a result of screening by ELISA, 28-well hybridomas were selected from among the 600-well hybrididomas that formed the colonies.</span>
  </div>
  <div id="p0150" num="0150" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 陽性株として選んだハイプリ ドーマ 28クローンの上清を、 ヒトプレ B白血病 細胞株 N a 1 m 6の細胞表面に発現しているプレ B細胞レセプ夕一と反応させ細 胞表面染色を行い、 ファックスキヤリバ一 （FACS Cal ibur、 ベク ト ンデッキンソン社製） にて測定した結果、 前記 2 8クローン中、 7クローンが N a lm6で陽性となり、 Daud iおよび L BW— 4で陰性となった。 

 細胞表面染色と同様にして、 細胞および抗体を懸濁する緩衝液を 0. 1%BS A— 0. 05%サポニンー 10111]^ Hepes (pH7. 3) 一 PBSとして、 細胞内染色を行い、 ファックスキヤリバ一にて測定した結果、 前記 7クローン中、 1クローンが N a lm6で陽性となり、 Daud iおよび L B W— 4で陰性とな つた。 </span>The supernatant of the 28 clones of the hybridoma selected as a positive strain was reacted with the pre-B cell receptor expressed on the cell surface of the human pre-B leukemia cell line Na1m6, and the cell surface was stained. As a result of measurement with Ribai (FACS Cal ibur, manufactured by Vectorton Dickinson), 7 out of the 28 clones were positive for Nalm6 and negative for Daudi and LBW-4.  In the same manner as for cell surface staining, use 0.1% BSA-0.05% saponin-10111] ^ Hepes (pH 7.3) in PBS as a buffer to suspend cells and antibodies, perform intracellular staining, and fax As a result of measurement using a carrier, one of the seven clones was positive for Nalm6 and negative for Daudi and LBW-4.</span>
  </div>
  <div id="p0151" num="0151" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 最終的に残った 1クローンのハイプリ ドーマを限界希釈法により、 96穴ブレ —トに 1細胞/ゥエルとなるように撒いた後、 10日間培養した。 1コロニー/ ゥエルとなったコロニーを 10個選択し、 EL I SA条件 2にて EL I SA法に より、 Aのコーティングでの吸光度を測定した。 最も吸光度が高くなつたハイブ リ ドーマを HSL2と名付け、 該ハイブリ ドーマを日本国茨城県つくば巿東 1丁 目 1番 3号、 通商産業省工業技術院生命工学工業技術研究所に、 受託番号 FER M-P 16476で平成 9年 10月 16日に原寄託し、 さらに平成 10年 5月 2 5曰に、 国際寄託当局である日本国茨城県つくば巿東 1丁目 1番 3号、 通商産業 省工業技術院生命工学工業技術研究所に、 受託番号 FERM— BP 6378で移 管した。 このハイプリ ドーマ HSL 2が産生する抗体を HSL 2抗体と呼ぶ。 また、 同様の操作で、 ヒト preB細胞レセプターを認識する抗体で、 特に入 5を認識する抗体が取得された。 この抗体を産生するハイプリ ドーマを HSL 1 1と名付けた。 このハイプリ ドーマが産生する抗体を HS L 11抗体と呼ぶ。 実施例 1の 4. と同様にして HSL 2抗体の大量生産を行い、 モノクローナル マウス I gァイソタイピングキット （ファーミンジェン社製） を用いて該抗体の サブクラスが I であることを確認した。 </span>&nbsp;The remaining hybrididoma of one clone was finally seeded on a 96-well plate at 1 cell / well by limiting dilution, and then cultured for 10 days. Ten colonies that became 1 colony / well were selected, and the absorbance at the coating of A was measured by the ELISA method under the ELISA condition 2. The hybridoma with the highest absorbance was named HSL2. Original deposit on October 16, 1997 with MP 16476, and on May 25, 1998, the International Depositary Authority, 1-3-1, Tsukuba-Higashi, Ibaraki, Japan, Ministry of International Trade and Industry Transferred to the National Institute of Bioscience and Biotechnology under the accession number FERM-BP 6378. The antibody produced by the hybridoma HSL 2 is called an HSL 2 antibody. In the same manner, an antibody recognizing the human preB cell receptor, particularly an antibody recognizing input 5 was obtained. The hybridoma producing this antibody was named HSL11. The antibody produced by this hybridoma is referred to as HSL11 antibody. HSL2 antibody was mass-produced in the same manner as 4 in Example 1, and the subclass of the antibody was confirmed to be I using a monoclonal mouse Ig isotyping kit (Pharmingen).</span>
  </div>
  <div id="p0152" num="0152" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> &lt;実施例 3 &gt;抗体の特異性の確認 1一 E L I S A法 </span>&nbsp;&lt;Example 3&gt; Confirmation of antibody specificity</span>
  </div>
  <div id="p0153" num="0153" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> EL I S A条件 2と同様の条件で、 下記各試料を下記各コ一ティングした抗原 蛋白質と反応させ、 405 nmでの吸光度を測定した。 </span>&nbsp;The following samples were reacted with the following coated antigen proteins under the same conditions as ELISA Conditions 2, and the absorbance at 405 nm was measured.</span>
  </div>
  <div id="p0154" num="0154" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> コーティングした抗原蛋白質： </span>&nbsp;Coated antigen protein:</span>
  </div>
  <div id="p0155" num="0155" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ① Lt k一 17-72の培養上清の 10倍濃縮液 （プレ B細胞レセプ 

夕一） </span>(1) A 10-fold concentrate of the culture supernatant of Ltk-17-72 (pre-B cell receptor  Yuichi)</span>
  </div>
  <div id="p0156" num="0156" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ②ヒト I gM (ヒト 鎖およびヒト 鎖） （ 10〃g/ml) </span>&nbsp;②Human IgM (human chain and human chain) (10 （g / ml)</span>
  </div>
  <div id="p0157" num="0157" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ③ヒト I gM (ヒト〃鎖およびヒト入鎖） （ 10 zg/ml) </span>&nbsp;③ Human IgM (human 〃 chain and human input chain) (10 zg / ml)</span>
  </div>
  <div id="p0158" num="0158" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> s»i料： </span>&nbsp;s »i fee:</span>
  </div>
  <div id="p0159" num="0159" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ①ハイプリ ドーマ HSL 2の培養上清 （HSL 2抗体） </span>&nbsp;(1) Culture supernatant of Hypri-Doma HSL 2 (HSL 2 antibody)</span>
  </div>
  <div id="p0160" num="0160" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ②ハイプリ ドーマ HSL96の培養上清 （HSL96抗体） </span>&nbsp;(2) Culture supernatant of Hypri-Doma HSL96 (HSL96 antibody)</span>
  </div>
  <div id="p0161" num="0161" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ③ハイプリ ドーマ HSL 11の培養上清 （HSL 11抗体） </span>&nbsp;(3) Culture supernatant of Hypri-Doma HSL 11 (HSL 11 antibody)</span>
  </div>
  <div id="p0162" num="0162" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ④マウスハイプリ ドーマ 141 PF 11の培養上清 （抗ヒト 鎖抗体）</span>&nbsp;培養 Culture supernatant of mouse Hypri-Doma 141 PF 11 (anti-human chain antibody)</span>
  </div>
  <div id="p0163" num="0163" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">⑤マウスハイプリ ドーマ HP 6054の培養上清 （抗ヒト人鎖抗体） </span>培養 Culture supernatant of mouse Hypri-Doma HP 6054 (anti-human human chain antibody)</span>
  </div>
  <div id="p0164" num="0164" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 検出用抗体： </span>&nbsp;Antibody for detection:</span>
  </div>
  <div id="p0165" num="0165" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> アル力リフォスファタ一ゼ標識ャギ抗マウス I gG抗体の 500倍希釈液 基質： P N P P </span>&nbsp;A 500-fold diluted solution of goat anti-mouse IgG antibody labeled with lipophilic phosphatase Substrate: PNPPP</span>
  </div>
  <div id="p0166" num="0166" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 結果を図 3 Aから図 3 Cに示す。 H S L 2抗体はプレ B細胞レセプ夕一を認 識し、 ヒト /鎖、 鎖または人鎖とは反応しないことが分かる。 したがって、 H S L 2はヒトプレ B細胞レセプ夕一の〃鎖の部分のみを認識しているわけではな いことが分かった。 また、 H S L 96抗体はヒト〃鎖、 鎖またはえ鎖とは反応 しないことがわかった。 </span>&nbsp;The results are shown in FIGS. 3A to 3C. The HSL2 antibody recognizes the pre-B cell receptor and does not react with human / chain, chain or human chain. Therefore, it was found that HSL2 did not recognize only the 〃 chain portion of the human pre-B cell receptor. Also, it was found that the HSL96 antibody did not react with the human 〃 chain, chain or fly chain.</span>
  </div>
  <div id="p0167" num="0167" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> く実施例 4 &gt;抗体の特異性の確認 2— F A C S法 </span>&nbsp;Example 4&gt; Confirmation of antibody specificity 2—FACS method</span>
  </div>
  <div id="p0168" num="0168" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 1. 細胞表面免疫染色 </span>&nbsp;1. Cell surface immunostaining</span>
  </div>
  <div id="p0169" num="0169" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 下記細胞株と HS L 2抗体または H S L 96抗体をそれぞれ反応させて、 細胞 表面染色を行い、 ファックスキヤリバ一 （FACS Cal ibur、 べクトン デッキンソン社製） にて測定した。 </span>&nbsp;The following cell lines were reacted with the HS L2 antibody or the HS L 96 antibody, respectively, and cell surface staining was performed. The cell surface was stained with a Fascilla Riva (FACS Cal ibur, manufactured by Becton Dickinson).</span>
  </div>
  <div id="p0170" num="0170" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 細胞株： </span>&nbsp;Cell lines:</span>
  </div>
  <div id="p0171" num="0171" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ①プロ B白血病細胞株 RS 4 ； 11 </span>&nbsp;① Pro B leukemia cell line RS 4; 11</span>
  </div>
  <div id="p0172" num="0172" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ②プレ B白血病細胞株 697 </span>&nbsp;② Pre-B leukemia cell line 697</span>
  </div>
  <div id="p0173" num="0173" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ③成熟 B細胞株 LBW - 4 

 ④ T白血病細胞株 J u r k a t </span>③ Mature B cell line LBW-4  ④ T leukemia cell line J urkat</span>
  </div>
  <div id="p0174" num="0174" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 具体的には、 0. 1 %BS A— PBSで 2回洗浄した各細胞を緩衝液 0. 1</span>&nbsp;Specifically, each cell washed twice with 0.1% BSA-PBS was added to buffer 0.1.</span>
  </div>
  <div id="p0175" num="0175" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">%BSA— PBSに 2X 10<sup class="style-scope patent-text">7</sup> 個/ mlになるように懸濁し、 10分間氷上で 静置した。 各細胞を 96穴プレートの各ゥエルに 50〃1 ( 1 X 10<sup class="style-scope patent-text">6</sup>個） 取り、 それぞれにピオチン標識 HSL 2抗体またはビォチン標識 HSL 96抗体を ΐ ό g/mlを 100^1加え、 室温で 30分間反応させた。 その後、 PE標識スト レブ卜アビジン （2 g/ml) を 100〃 1各ゥエルに加え、 発色させた。 </span>The cells were suspended at 2 × 10 <sup class="style-scope patent-text">7</sup> cells / ml in% BSA-PBS and left on ice for 10 minutes. Transfer 50 細胞 1 (1 × 10 <sup class="style-scope patent-text">6</sup> ) of each cell to each well of a 96-well plate, add 100 μl of チ ン ό g / ml of biotin-labeled HSL 2 antibody or biotin-labeled HSL 96 antibody to each well, and add Allowed to react for minutes. Then, 100 μl of PE-labeled streptavidin (2 g / ml) was added to each well to develop color.</span>
  </div>
  <div id="p0176" num="0176" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> この試料を、 ファックスキヤリバ一 （FACS Cal ibur、 ぺクトン デヅキンソン社製） にて測定した。 </span>&nbsp;This sample was measured using a FAX scanner (FACS Cal ibur, manufactured by Pecton Dickinson).</span>
  </div>
  <div id="p0177" num="0177" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 結果を図 4 Aから図 4Hに示す。 細胞表面染色においては、 HSL2抗体また は HSL96抗体によりプレ B白血病細胞が免疫染色されるが、 プロ B白血病細 胞株、 成熟 B細胞株および T白血病細胞株は H SL2によっては免疫染色されな いことが確認された。 </span>&nbsp;The results are shown in FIGS. 4A to 4H. In cell surface staining, pre-B leukemia cells are immunostained by HSL2 antibody or HSL96 antibody, but pro-B leukemia cell lines, mature B cell lines, and T leukemia cell lines are not immunostained by HSL2. It was confirmed that.</span>
  </div>
  <div id="p0178" num="0178" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 2. 細胞内免疫染色 </span>&nbsp;2. Intracellular immunostaining</span>
  </div>
  <div id="p0179" num="0179" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 前記の細胞表面染色と同様にして、 細胞および抗体を懸濁するサポニン緩衝 液を 0. l%BSA—0. 05%サポニン一10mM He p e s (pH 7. 3 ) 一 PBSとして、 細胞内染色を行い、 ファックスキヤリバ一にて測定した。 結果を図 5 Aから図 5 Hに示す。 HSL2抗体により、 プレ B白血病細胞株は 細胞内も免疫染色されるが、 プロ B白血病細胞株、 成熟 B細胞株および T白血病 細胞株は細胞内も免疫染色されないことが確認された。 また、 HSL96抗体は、 細胞内染色においては、 プロ B白血病細胞株を免疫染色することが確認された。 プロ B細胞の細胞内染色において、 HS L 2抗体と HSL 96抗体とはそれぞれ 異なった効果を奏するものである。 </span>&nbsp;In the same manner as in the cell surface staining described above, the saponin buffer for suspending cells and antibodies was used as 0.1% BSA-0.05% saponin- 10 mM Hepes (pH 7.3) -PBS, and intracellular staining was performed. The measurement was performed with a fax scanner. The results are shown in FIGS. 5A to 5H. It was confirmed that the HSL2 antibody also immunostains the pre-B leukemia cell line in the cells, but does not immunostain the pro-B leukemia cell line, the mature B cell line, and the T leukemia cell line. In addition, it was confirmed that the HSL96 antibody immunostains a pro-B leukemia cell line in intracellular staining. The HSL2 antibody and the HSL96 antibody exert different effects on intracellular staining of pro-B cells.</span>
  </div>
  <div id="p0180" num="0180" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 3. 形質転換体 X63— Ag 8. 653の細胞内免疫染色 </span>&nbsp;3. Intracellular immunostaining of transformant X63—Ag8.653</span>
  </div>
  <div id="p0181" num="0181" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> マウスミエローマ細胞 X 63—Ag 8. 653 (J. Immuno l. , 1</span>&nbsp;Mouse myeloma cells X 63—Ag8.653 (J. Immunol., 1</span>
  </div>
  <div id="p0182" num="0182" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">23巻、 1548ページ参照） に実施例 1の 1. で作製したヒト人 5遺伝子また 

はヒト Vp r e B遺伝子をエレクトロポ一レーシヨン法により下記の 2通りに導 入し、 形質転換体を作製した。 </span>(See Vol. 23, p. 1548.)  Introduced the human Vpre B gene by the electroporation method in the following two ways to prepare a transformant.</span>
  </div>
  <div id="p0183" num="0183" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ①人 5のみを導入 （X63/Λ5) </span>&nbsp;①Introduce only 5 people (X63 / Λ5)</span>
  </div>
  <div id="p0184" num="0184" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ② VpreBのみを導入 （X63/VpreB) </span>&nbsp;② Introduce only VpreB (X63 / VpreB)</span>
  </div>
  <div id="p0185" num="0185" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 前記の各形質転換体について、 前記と同様にサポニン緩衝液を用いて細胞内 免疫染色を行い、 ファックスキヤリバ一にて測定した。 </span>&nbsp;For each of the above transformants, intracellular immunostaining was carried out using a saponin buffer in the same manner as described above, and measurement was performed using a fax scanner.</span>
  </div>
  <div id="p0186" num="0186" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 結果を図 6 Aから図 6 Dに示す。 H S L 2抗体が組み換え Vp r eB分子また は組み換え λ 5分子のいずれとも反応しないことが確認された一方で、 H S L 9 6抗体は、 組み換え VpreB分子とは反応するが、 組み換えん 5分子とは反応 しないことが確認された。 </span>&nbsp;The results are shown in FIGS. 6A to 6D. It was confirmed that the HSL2 antibody did not react with either the recombinant VpreB molecule or the recombinant λ5 molecule, while the HSL96 antibody reacted with the recombinant VpreB molecule but reacted with the 5 recombinant molecules. Not confirmed.</span>
  </div>
  <div id="p0187" num="0187" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> &lt;実施例 5 &gt;抗体の特異性の確認 3—免疫沈降 </span>&nbsp;&lt;Example 5&gt; Confirmation of antibody specificity 3—Immunoprecipitation</span>
  </div>
  <div id="p0188" num="0188" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ハイブリ ドーマ H S L 2の培養上清 1 mlをプロテイン Gセファロ一ス （ファ ルマシア社製） 20〃1と （50%V/V) と 4 °Cで一晩混合した。 </span>&nbsp;1 ml of the culture supernatant of the hybridoma HSL2 was mixed overnight with Protein G Sepharose (Pharmacia) 20〃1 and (50% V / V) at 4 ° C.</span>
  </div>
  <div id="p0189" num="0189" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> この混合液を 10000 r pmで 5分間遠心分離して抗体が結合したプロティ ン Gセファロースを取り分けた。 </span>&nbsp;This mixture was centrifuged at 10,000 rpm for 5 minutes to separate out the antibody-bound Protein G Sepharose.</span>
  </div>
  <div id="p0190" num="0190" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 該プロテイン Gセファロ一スを溶解液 （ 1 %NP— 40、 15 OmM NaC 1) で洗浄した。 </span>&nbsp;The protein G Sepharose was washed with a lysis solution (1% NP-40, 15 OmM NaCl).</span>
  </div>
  <div id="p0191" num="0191" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> アイソト一プ <sup class="style-scope patent-text">35</sup> Sメチォニン · システィンで内部標識したプレ B白血病細胞 株 Na lm6またはプロ B白血病細胞株 RS 4 ； 1 1を 1 x 10<sup class="style-scope patent-text">5</sup>個と溶解液 （ 1%NP— 40、 15 OmM N a C 1 ) とを混合し細胞溶解液を得た。 </span>Pre-B leukemia cell line Nalm6 or pro-B leukemia cell line RS4; internally labeled with isotope <sup class="style-scope patent-text">35</sup> S-methionine cysteine; 1 x 10 <sup class="style-scope patent-text">5</sup> cells and lysate (1% NP-40, 15 OmM Na And C 1) to obtain a cell lysate.</span>
  </div>
  <div id="p0192" num="0192" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 抗体結合プロティン Gセファロースを細胞溶解液に懸濁し、 2時間混合した。 別に、 前記培養上清を実施例 2で作製した 2種の X63_Ag 8. 653形質 転換体と反応させた。 </span>&nbsp;Antibody-bound protein G Sepharose was suspended in the cell lysate and mixed for 2 hours. Separately, the culture supernatant was reacted with the two X63_Ag8.653 transformants prepared in Example 2.</span>
  </div>
  <div id="p0193" num="0193" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> この混合液を 10000 r pmで 5分間遠心分離して免疫沈降物 （前記プロテ イン Gセファロースに結合した Nalm6由来の蛋白質） を取り分けた。 </span>&nbsp;This mixture was centrifuged at 10,000 rpm for 5 minutes to separate immunoprecipitates (the Nalm6-derived protein bound to the protein G Sepharose).</span>
  </div>
  <div id="p0194" num="0194" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 比較対照のため以下の抗体を用いた。 

 ① HSL 11抗体 （ヒトプレ B細胞レセプターの人 5を認識する抗体）</span>The following antibodies were used for comparison.  ① HSL 11 antibody (An antibody that recognizes human pre-B cell receptor 5)</span>
  </div>
  <div id="p0195" num="0195" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">② HSL96抗体 （ヒトプレ B細胞レセプ夕一の Vp re Bを認識する抗体）</span>② HSL96 antibody (An antibody that recognizes Vpre B of human pre-B cell receptor Yuichi)</span>
  </div>
  <div id="p0196" num="0196" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">③コントロール （マウス I gG ） </span>③ Control (mouse IgG)</span>
  </div>
  <div id="p0197" num="0197" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ④抗ヒト 鎖抗体 （細胞溶解物の免疫沈降の場合のみ） </span>&nbsp;④Anti-human chain antibody (only for immunoprecipitation of cell lysate)</span>
  </div>
  <div id="p0198" num="0198" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 免疫沈降物を洗浄液 （ 1 %NP— 40、 65 OmM NaCl)約 lmlで洗 浄することを 4回繰り返し、 電気泳動用の試料とした。 </span>&nbsp;Washing of the immunoprecipitate with about 1 ml of a washing solution (1% NP-40, 65 OmM NaCl) was repeated four times to obtain a sample for electrophoresis.</span>
  </div>
  <div id="p0199" num="0199" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 免疫沈降物を 2—メルカプトエタノール存在下で 95°Cで 5分間還元した後、 13%アクリルアミ ドゲルに展開した。 </span>&nbsp;The immunoprecipitate was reduced at 95 ° C for 5 minutes in the presence of 2-mercaptoethanol, and then developed on a 13% acrylamide gel.</span>
  </div>
  <div id="p0200" num="0200" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 結果を図 7および図 8に示す。 </span>&nbsp;The results are shown in FIGS.</span>
  </div>
  <div id="p0201" num="0201" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 図 7の右半分はプレ B白血病細胞株 N a 1 m 6の細胞溶解物を各抗体で免疫沈 降した結果を示す。 各レーンは、 右から HSL2抗体、 HSL 11抗体、 HSL 96抗体、 抗ヒト〃鎖抗体、 コントロール （マウス I ） により免疫沈降 した結果を示す。 HSL 2抗体または HSL 96抗体により免疫沈降した結果、 λ5、 Vp r eBおよび〃鎖のバンドが現れ、 H S L 2抗体でプレ B細胞レセプ 夕一が免疫沈降されたことが確認された。 </span>&nbsp;The right half of FIG. 7 shows the results of immunoprecipitation of the cell lysate of the pre-B leukemia cell line Na1m6 with each antibody. Each lane shows the results of immunoprecipitation with the HSL2 antibody, HSL11 antibody, HSL96 antibody, anti-human 〃 chain antibody, and control (mouse I) from the right. As a result of immunoprecipitation with the HSL2 antibody or the HSL96 antibody, bands of λ5, VpreB and 〃 chain appeared, and it was confirmed that the pre-B cell receptor was immunoprecipitated with the HSL2 antibody.</span>
  </div>
  <div id="p0202" num="0202" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 図 7の左半分はプロ B白血病細胞株 RS 4； 11の細胞溶解物を各抗体で免疫 沈降した結果を示す。 各レーンは、 右から HSL2抗体、 HSL 11抗体、 HS L 96抗体、 抗ヒト 鎖抗体、 コントロール （マウス IgGiA：) により免疫沈 降した結果を示す。 左端のレーンはマーカーである。 HS L 2抗体のレーンには、 λ 5および Vp r e Bのバンドが見られず、 H S L 2抗体でプロ B細胞レセプ夕 —が免疫沈降されないことが確認された。 </span>&nbsp;The left half of FIG. 7 shows the results of immunoprecipitation of the cell lysate of the pro B leukemia cell line RS 4; 11 with each antibody. Each lane shows the results of immunoprecipitation with the HSL2 antibody, HSL11 antibody, HSL96 antibody, anti-human chain antibody, and control (mouse IgGiA :) from the right. The leftmost lane is a marker. No lambda 5 and VpreB bands were observed in the HS L2 antibody lane, confirming that the HS B2 antibody did not immunoprecipitate the pro-B cell receptor.</span>
  </div>
  <div id="p0203" num="0203" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 図 8の左半分は組み換え人 5を各抗体で免疫沈降させた結果を示す。 各レー ンは、 右から HSL2抗体、 HSL 11抗体、 HSL96抗体、 コントロール （ マウス IgGi ） により免疫沈降した結果を示す。 HSL2抗体または HSL 96抗体のレーンには、 人 5のバンドが見られず、 113 2抗体または113]^9 6抗体で人 5が免疫沈降されないことが確認された。 

 図 8の左半分は組み換え Vp r eBを各抗体で免疫沈降させた結果を示す。 各 レーンは、 右から HS L 2抗体、 HSL 11抗体、 HSL 96抗体、 コント口一 ル （マウス I
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/1d/30/be/66ef95ea4732a8/imgf000026_0001.png" class="style-scope patent-text"><img id="imgf000026_0001" he="6" wi="15" file="imgf000026_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no" width="60" height="24" alt="Figure imgf000026_0001" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/1d/30/be/66ef95ea4732a8/imgf000026_0001.png"></a></div>
 ) により免疫沈降した結果を示す。 HSL2抗体のレー ンには、 Vp r eBのバンドが見られず、 H S L 2抗体で Vp r e Bが免疫沈降 されないことが確認された。 HSL 96抗体のレーンには、 VpreBのバンドが みられた。 </span>The left half of FIG. 8 shows the result of immunoprecipitation of recombinant 5 with each antibody. Each lane shows the results of immunoprecipitation with the HSL2 antibody, HSL11 antibody, HSL96 antibody, and control (mouse IgGi) from the right. No band of human 5 was seen in the HSL2 antibody or HSL 96 antibody lane, confirming that human 5 was not immunoprecipitated with the 1132 antibody or 113] ^ 96 antibody.  The left half of FIG. 8 shows the result of immunoprecipitation of the recombinant VpreB with each antibody. In each lane, from the right, HSL2 antibody, HSL11 antibody, HSL96 antibody, control (mouse I <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/1d/30/be/66ef95ea4732a8/imgf000026_0001.png" class="style-scope patent-text"><img id="imgf000026_0001" he="6" wi="15" file="imgf000026_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no" width="60" height="24" alt="Figure imgf000026_0001" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/1d/30/be/66ef95ea4732a8/imgf000026_0001.png"></a></div> ) Shows the results of immunoprecipitation. No VpreB band was observed in the HSL2 antibody lane, confirming that the HSL2 antibody did not immunoprecipitate VpreB. The VpreB band was observed in the HSL 96 antibody lane.</span>
  </div>
  <div id="p0204" num="0204" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> &lt;実施例 6 &gt;免疫染色した細胞の顕微鏡での観察 </span>&nbsp;&lt;Example 6&gt; Microscopic observation of immunostained cells</span>
  </div>
  <div id="p0205" num="0205" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 1. 免疫染色したプレ B細胞の顕微鏡での観察 </span>&nbsp;1. Microscopic observation of immunostained pre-B cells</span>
  </div>
  <div id="p0206" num="0206" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> プレ B白血病細胞株 N a lm6およびプロ B白血病細胞株 RS 4； 11を実 施例 4の 1. と同様にして、 ピオチン標識 HSL 2抗体と反応させて細胞内を免 疫染色した。 F I TC標識ストレブトアビジンをピオチン標識 HSL 2抗体と反 応させ、 その蛍光を蛍光顕微鏡で観察した。 結果を図 9に示す。 プレ B白血病細 胞株 Na lm6では蛍光が観察されるが、 プロ B白血病細胞株 RS 4； 11は蛍 光が観察されなかった。 これにより、 HSL 2抗体を反応させて細胞内免疫染色 した結果、 顕微鏡観察することで、 容易にプレ B細胞とプロ B細胞を区別し、 プ レ B細胞のみを検出することができることが確認された。 </span>&nbsp;The pre-B leukemia cell line Nalm6 and the pro-B leukemia cell line RS4; 11 were reacted with a biotin-labeled HSL2 antibody in the same manner as in 1. of Example 4 to immunostain the cells. FITC-labeled streptavidin was reacted with a biotin-labeled HSL2 antibody, and the fluorescence was observed with a fluorescence microscope. Fig. 9 shows the results. Fluorescence was observed in the pre-B leukemia cell line Nalm6, but no fluorescence was observed in the pro-B leukemia cell line RS4; 11. As a result, intracellular immunostaining with the reaction of HSL 2 antibody confirmed that microscopic observation made it possible to easily distinguish pre-B cells from pro-B cells and to detect only pre-B cells. Was.</span>
  </div>
  <div id="p0207" num="0207" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> また、 細胞表面を染色した場合も、 同様に HSL 2抗体によりプレ B細胞のみ で蛍光が観察され、 プレ B細胞のみを検出することができることが確認された。 </span>&nbsp;Also, when the cell surface was stained, similarly, fluorescence was observed only in the pre-B cells by the HSL2 antibody, confirming that only the pre-B cells could be detected.</span>
  </div>
  <div id="p0208" num="0208" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> &lt;実施例 7 &gt;免疫染色した細胞の顕微鏡での観察 </span>&nbsp;&lt;Example 7&gt; Microscopic observation of immunostained cells</span>
  </div>
  <div id="p0209" num="0209" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 1. 免疫染色したプレ B細胞の顕微鏡での観察 </span>&nbsp;1. Microscopic observation of immunostained pre-B cells</span>
  </div>
  <div id="p0210" num="0210" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> プレ B白血病細胞株 Na lm6を実施例 4の 1. と同様にして、 ピオチン標 識 H S L 96抗体と反応させて細胞内を免疫染色した。 FIT C標識ストレブト アビジンをピオチン標識 HSL 96抗体と反応させ、 その蛍光を蛍光顕微鏡で観 察した。 結果を図 10に示す。 F I TCの蛍光が観察される細胞が Na lm6で ある。 これにより、 HSL 96抗体を反応させて細胞内免疫染色した結果、 顕微 鏡観察することで、 容易にプレ B細胞を検出することができることが確認された c 

 2. 免疫染色したプロ B細胞の顕微鏡での観察 </span>The pre-B leukemia cell line Nalm6 was reacted with a biotin-labeled HSL 96 antibody in the same manner as in 1. of Example 4 to immunostain the cells. FITC-labeled streptavidin was reacted with a biotin-labeled HSL 96 antibody, and the fluorescence was observed with a fluorescence microscope. The results are shown in FIG. The cell where fluorescence of FITC is observed is Nalm6. As a result, intracellular immunostaining was performed by reacting with the HSL96 antibody, and it was confirmed that pre-B cells could be easily detected by microscopic observation.c  2. Microscopic observation of immunostained pro B cells</span>
  </div>
  <div id="p0211" num="0211" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> プロ B白血病細胞株 N a lm27を実施例 3の 2. と同様にして、 ピオチン 標識 HSL96抗体と、 サポニン緩衝液を用いて反応させて細胞内を免疫染色し た。 FIT C標識ストレブトアビジンをピオチン標識 HS L 96抗体と反応させ、 その蛍光を蛍光顕微鏡で観察した。 結果を図 11に示す。 図 11八が113 96 抗体を反応させた結果の顕微鏡写真であり、 図 1 1 Bが対照として HSL 96抗 体の代わりにマウス I gG!/cを反応させた場合の顕微鏡写真である。 F I TC の蛍光が観察される細胞が N a lm27である。 これにより、 HSL96抗体を プロ B細胞に反応させて細胞内免疫染色した結果、 顕微鏡観察することで、 容易 にプロ B細胞を検出することができることが確認された。 </span>&nbsp;The proB leukemia cell line Nalm27 was reacted with a biotin-labeled HSL96 antibody using a saponin buffer in the same manner as in 2. of Example 3 to immunostain the cells. FITC-labeled streptavidin was reacted with a biotin-labeled HS L96 antibody, and the fluorescence was observed with a fluorescence microscope. The results are shown in FIG. Fig. 118 shows micrographs of the result of the reaction with the 11396 antibody, and Fig. 11B shows the micrograph of the case where mouse IgG! / C was reacted instead of the HSL96 antibody as a control. The cell in which the fluorescence of FITC is observed is Nalm27. As a result, the HSL96 antibody was reacted with pro-B cells and subjected to intracellular immunostaining. As a result, it was confirmed that pro-B cells could be easily detected by microscopic observation.</span>
  </div>
  <div id="p0212" num="0212" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 前記の実施例 3ないし 5の特異性の結果を、 表 1に示した抗体の特異性と合わ せて表 2に示す。 既存の抗体の反応部位は I 5のみまたは Vp r e Bのみであり、 ヒト〃鎖、 ヒトえ 5およびヒ卜 Vp r e Bの複合体を認識している抗体は H S L 2のみである。 

</span>The results of the specificities of Examples 3 to 5 are shown in Table 2 together with the specificities of the antibodies shown in Table 1. The reaction site of the existing antibody is only I5 or only VpreB, and HSL2 is the only antibody that recognizes the complex of human 〃 chain, human protein 5 and human VpreB. </span>
  </div>
  <div id="p0213" num="0213" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ro </span>ro</span>
  </div>
  <div id="p0214" num="0214" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text">
      <span class="google-src-text style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/42/dd/a0/49ccb1f89249bd/imgf000028_0001.png" class="style-scope patent-text"><img id="imgf000028_0001" he="114" wi="220" file="imgf000028_0001.tif" img-format="tif" img-content="drawing" orientation="landscape" inline="no" width="880" height="456" alt="Figure imgf000028_0001" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/42/dd/a0/49ccb1f89249bd/imgf000028_0001.png"></a></div>
        
      </span>
      <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/42/dd/a0/49ccb1f89249bd/imgf000028_0001.png" class="style-scope patent-text"><img id="imgf000028_0001" he="114" wi="220" file="imgf000028_0001.tif" img-format="tif" img-content="drawing" orientation="landscape" inline="no" width="880" height="456" alt="Figure imgf000028_0001" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/42/dd/a0/49ccb1f89249bd/imgf000028_0001.png"></a></div>
      
    </span>
  </div>
  <div id="p0215" num="0215" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">本発明の HSL2抗体は、 ヒト 鎖、 ヒト λ 5またはヒト Vp r eBのいず れとも、 それらが単体で存在するときにはそれらを認識せず、 ヒト〃鎖、 ヒト λ 5およびヒト Vp r eBが会合してプレ Β細胞レセプ夕一となつたときに、 初め て該プレ B細部レセプ夕一を認識する抗体であることが分かった。 すなわち、 プ レ B細胞レセプ夕一の立体構造が HS L 2抗体が該プレ B細胞レセプ夕一を認識 する要件であることが分かつた。 </span>The HSL2 antibody of the present invention does not recognize human chain, human λ5 or human VpreB when they exist alone, and does not recognize human 〃 chain, human λ5 and human VpreB. When it associates with the pre-cell receptor, it was found that the antibody was the first to recognize the pre-B detail receptor. That is, it was found that the three-dimensional structure of the pre-B cell receptor was a requirement for the HSL2 antibody to recognize the pre-B cell receptor.</span>
  </div>
  <div id="p0216" num="0216" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 本発明の HSL96抗体は、 組み換え Vpr eB分子単体と反応することが確 かめられているので、 プロ B細胞と細胞内において Vp r eB分子と反応してい ることが考えられる。 </span>&nbsp;Since it has been confirmed that the HSL96 antibody of the present invention reacts with the recombinant VprEB molecule alone, it is considered that the antibody reacts with the VprEB molecule in pro-B cells and intracellularly.</span>
  </div>
  <div id="p0217" num="0217" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 本発明の H S L 96抗体は、 プレ B細胞およびプロ B細胞のいずれについて も細胞内染色が可能であるが、 従来の抗体ではこのような知見はない。 </span>&nbsp;The HSL96 antibody of the present invention is capable of intracellular staining of both pre-B cells and pro-B cells, but there is no such finding with conventional antibodies.</span>
  </div>
  <div id="p0218" num="0218" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> また、 本発明の HSL 96抗体は、 実施例 7で示したように、 免疫染色した細 胞を顕微鏡で観察することが可能であるが、 従来の抗体ではこのような知見はな い。 </span>&nbsp;In addition, as shown in Example 7, the HSL96 antibody of the present invention can observe immunostained cells with a microscope, but there is no such finding with a conventional antibody.</span>
  </div>
  <div id="p0219" num="0219" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">産業上の利用可能性 </span>Industrial applicability</span>
  </div>
  <div id="p0220" num="0220" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 本発明の抗体により、 ヒトのリンパ球の中からヒトプロ B細胞およびヒトプレ B細胞の識別が可能となる。 </span>&nbsp;The antibody of the present invention enables human pro-B cells and human pre-B cells to be distinguished from human lymphocytes.</span>
  </div>
  <div id="p0221" num="0221" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 本発明の抗体のうち、 ヒトプレ B細胞を認識しかつプロ B細胞を認識しない抗 体により染色された細胞の細胞表面あるいは細胞内が染色されていることが観察 された場合、 該細胞はヒトプレ B細胞であると特定できる。 また染色されなかつ た細胞がもう一方の抗体で染色された場合はプロ B細胞と特定できる。 本発明の Vp r eBを認識する抗体は、 ヒトプレ B細胞レセプ夕一の代替軽鎖の VpreBに 反応して人 5とは反応しないが、 VpreBが軽鎖の可変領域に相当し、 人 5が定常 領域に相当することから、 本発明の抗体は、 ヒトプレ B細胞に反応する抗体の中 でも、 その特異性が高いものである。 </span>&nbsp;Among the antibodies of the present invention, when it is observed that the cell surface or the inside of cells stained with an antibody that recognizes human pre-B cells but does not recognize pro-B cells is stained, the cells are human pre-B cells. It can be identified as a cell. If the unstained cells are stained with the other antibody, they can be identified as pro-B cells. The antibody that recognizes VprEB of the present invention reacts with VpreB, an alternative light chain of human pre-B cell receptor, and does not react with human 5, but VpreB corresponds to the variable region of the light chain, and human 5 Since the antibody corresponds to the constant region, the antibody of the present invention has high specificity among antibodies that react with human pre-B cells.</span>
  </div>
  <div id="p0222" num="0222" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 小児急性リンパ性白血病の疑いのある患者の血液、 骨髄の検体からリンパ球を 

分離し、 該リンパ球の細胞表面または細胞内を本発明の抗体を組み合わせて免疫 染色してファックスキヤリバ一で観察する。 このとき、 染色されている細胞が観 察された場合、 該細胞はヒトプレ B細胞あるいはプロ B細胞であると特定でき、 該患者がヒトプレ B細胞の異常増殖あるいはプロ B細胞の異常増殖による白血病 に罹患していると診断することが可能となる。 従来の技術で小児急性リンノ 性白 血病が B細胞のどの分化段階由来であるかを細分化することができなかったが、 本発明の抗体により、 それが可能となる。 </span>Lymphocytes from blood and bone marrow specimens of patients with suspected pediatric acute lymphocytic leukemia  The cells are separated, and the cell surface or intracellular cells of the lymphocytes are immunostained with the antibody of the present invention in combination and observed with a fax scanner. At this time, if the stained cells are observed, the cells can be identified as human pre-B cells or pro-B cells, and the patient suffers from abnormal proliferation of human pre-B cells or leukemia due to abnormal proliferation of pro-B cells. It can be diagnosed as being affected. Although the prior art was unable to subdivide into which stage of B cell differentiation acute pediatric acute lymphoblastic leukemia originated, the antibody of the present invention makes that possible.</span>
  </div>
  <div id="p0223" num="0223" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> より具体的にいうと、 （1 )本発明の、 ヒトプレ B細胞レセプ夕一を認識しかつ ヒトプロ B細胞を認識しない抗体、 （2)VpreB分子を認識する抗体、 （3) 人 5分 子を認識する抗体および (4) B細胞を認識する抗体とを組み合わせて使用するこ とで、 小児急性リンパ性白血病が B細胞のどの分化段階由来であるか診断するこ とができる。 例えば、 検体と（1 )〜（4)の抗体とをそれぞれ反応させた結果、 （1 ) の抗体のみが検体を染色すれば、 該検体の患者はプレ B細胞由来の白血病である と分かる。 （2)の抗体のみが検体を染色すれば、 該検体の患者はプロ B細胞由来 と分かる。 </span>&nbsp;More specifically, (1) an antibody that recognizes human pre-B cell receptor but does not recognize human pro-B cells, (2) an antibody that recognizes VpreB molecule, and (3) a human pentamer according to the present invention. When used in combination with an antibody that recognizes and (4) an antibody that recognizes B cells, it is possible to diagnose at which stage of B cell differentiation childhood acute lymphoblastic leukemia originates. For example, as a result of reacting the specimen with the antibodies (1) to (4), if only the antibody (1) stains the specimen, it can be determined that the patient of the specimen has pre-B cell-derived leukemia. If only the antibody of (2) stains the specimen, it is known that the patient of the specimen is derived from pro-B cells.</span>
  </div>
  <div id="p0224" num="0224" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> このとき、 サポニン緩衝液を使用して細胞内を染色することにより、 従来より も容易にファックスキヤリバーで測定することができ、 従って診断も容易に行え る。 </span>&nbsp;At this time, by staining the inside of the cells using a saponin buffer, the measurement can be performed more easily with the Fax Scan River than before, and thus the diagnosis can be easily performed.</span>
  </div>
  <div id="p0225" num="0225" class="description-paragraph style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> また、 本発明の抗体は、 免疫染色した細胞を顕微鏡で観察する場合でも利用可 能である。 
</span>&nbsp;The antibody of the present invention can also be used when observing immunostained cells with a microscope.
</span>
  </div>
</div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result" hidden="">()</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result" hidden="">translated from </div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PCLM126431099" lang="EN" load-source="WIPO-OCR" class="claims ocr style-scope patent-text">
  <claim-statement class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">請求の範囲 </span> The scope of the claims</span>
  </claim-statement>
  <claim id="clm-0001" num="1" class="style-scope patent-text">
    <div class="claim-text style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 1. ヒトプレ B細胞レセプ夕一を認識し、 かつヒトプロ B細胞を認 識しない抗ヒトプレ B細胞レセプ夕一抗体。 </span>&nbsp;1. An anti-human pre-B cell receptor antibody that recognizes human pre-B cell receptor but does not recognize human pro-B cells.</span>
    </div>
  </claim>
  <claim id="clm-0002" num="2" class="style-scope patent-text">
    <div class="claim-text style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 2. ハイプリ ドーマ HSL2 (日本国茨城県つくば巿東 1丁目 1番 3号、 通商産業省工業技術院生命工学工業技術研究所に、 受託番号 FERM— P</span>&nbsp;2. Hypri-Dorma HSL2 (1-3-3 Tsukuba East Higashi, Ibaraki Prefecture, Japan; contracted with the Institute of Biotechnology, Institute of Biotechnology, Ministry of International Trade and Industry under the accession number FERM-P</span>
    </div>
    <div class="claim-text style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">16476で平成 9年 10月 16日に原寄託し、 さらに平成 10年 5月 25日に、 国際寄託当局である日本国茨城県つくば巿東 1丁目 1番 3号、 通商産業省工業技 術院生命工学工業技術研究所に、 受託番号 FERM— BP 6378で移管した。 ) が産生するモノクローナル抗体、 またはその活性フラグメントである、 請求項 1に記載の抗ヒトプレ B細胞レセプ夕一抗体。 </span>The original deposit was deposited on October 16, 1997 at 16476, and on May 25, 1998, International Depositary Authority 1-3-1, Tsukuba East, Ibaraki, Japan, Industrial Technology Institute of the Ministry of International Trade and Industry Transferred to Biotechnology Research Institute under accession number FERM-BP 6378. 2. The anti-human pre-B cell receptor antibody of claim 1, which is a monoclonal antibody produced by or) or an active fragment thereof.</span>
    </div>
  </claim>
  <claim id="clm-0003" num="3" class="style-scope patent-text">
    <div class="claim-text style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 3. ヒトプレ B細胞表面に発現しているヒトプレ B細胞レセプ夕一 を構成する代替軽鎖の Vp r eB分子、 およびヒトプロ B細胞内に発現している VpreB分子と反応し、 代替軽鎖のえ 5分子とは反応せず、 かつ該抗体が、 該 抗体によりヒトプレ B細胞またはヒトプロ B細胞を免疫染色して顕微鏡で観察す ることが可能な反応性を有することを特徴とする抗ヒトプレ B細胞レセプ夕一抗 体、 またはその活性フラグメント。 </span>&nbsp;3. Reacts with the VpreB molecule of the alternative light chain constituting the human pre-B cell receptor expressed on the surface of human pre-B cells and the VpreB molecule expressed in human pro-B cells, and An anti-human pre-B cell, which does not react with five molecules, and has a reactivity that allows the antibody to immunostain human pre-B cells or human pro-B cells with the antibody and to observe with a microscope. Recept Yuichi Antibody, or an active fragment thereof.</span>
    </div>
  </claim>
  <claim id="clm-0004" num="4" class="style-scope patent-text">
    <div class="claim-text style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 4. ハイプリ ドーマ HSL 96 (曰本国茨城県つくば巿東 1丁目 1 番 3号、 通商産業省工業技術院生命工学工業技術研究所に、 受託番号 FERM— P 16251で平成 9年 5月 30日に原寄託し、 さらに平成 10年 5月 25日に、 国際寄託当局である日本国茨城県つくば巿東 1丁目 1番 3号、 通商産業省工業技 術院生命工学工業技術研究所に、 受託番号 FERM— BP 6375で移管した。 ) が産生するモノクローナル抗体、 またはその活性フラグメントである請求項 1 に記載の抗体またはその活性フラグメント。 </span>&nbsp;4. Hypri-Dorma HSL 96 (Thailand, 1-3-1, Tsukuba-Higashi, Ibaraki Prefecture, Japan, with the Ministry of International Trade and Industry, Ministry of Industry and Technology, Institute of Biotechnology and Industrial Technology, with accession number FERM-P 16251 on May 30, 1997. Original deposit, and on May 25, 1998, the International Depositary Authority, 1-3-1, Tsukuba East Higashi, Ibaraki, Japan, and the Research Institute of Biotechnology, Industrial Technology Institute of the Ministry of International Trade and Industry of Japan The antibody or active fragment thereof according to claim 1, which is a monoclonal antibody produced by FERM-BP 6375.) or an active fragment thereof.</span>
    </div>
  </claim>
  <claim id="clm-0005" num="5" class="style-scope patent-text">
    <div class="claim-text style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 5. 請求項 3または 4に記載の抗体、 またはその活性フラグメント により、 検体中のヒトプロ B細胞を免疫染色して該ヒトプロ B細胞を検出するヒ トプロ B細胞の検出方法であって、 ヒトプロ B細胞内の Vp re B分子を免疫染 

色するときにサポニン緩衝液を用いることを特徴とするヒトプロ B細胞の検出方 法。 </span>5. A method for detecting human pro-B cells by immunostaining human pro-B cells in a sample with the antibody or the active fragment thereof according to claim 3, wherein the human pro-B cells are detected. Immunostaining of Vre B molecules  A method for detecting human pro-B cells, wherein a saponin buffer is used for coloring.</span>
    </div>
  </claim>
  <claim id="clm-0006" num="6" class="style-scope patent-text">
    <div class="claim-text style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 6. 小児急性リンパ性白血病が B細胞のどの分化段階由来であるかを 診断する診断薬であって、 （1)ヒトプレ B細胞レセプ夕一を認識し、 且つヒトプ 口 B細胞を認識しない抗体、 （2)Vr e pB分子を認識する抗体、 （3)λ5分子を 認識する抗体、 および (4)Β細胞を認識する抗体を少なくとも含むことを特徴と する診断薬。 </span>&nbsp;6. A diagnostic agent for diagnosing the stage of B cell differentiation from childhood acute lymphocytic leukemia, comprising: (1) an antibody that recognizes human pre-B cell receptors and does not recognize human oral B cells; A diagnostic agent comprising at least (2) an antibody that recognizes a VrepB molecule, (3) an antibody that recognizes a λ5 molecule, and (4) an antibody that recognizes Β cells.</span>
    </div>
  </claim>
  <claim id="clm-0007" num="7" class="style-scope patent-text">
    <div class="claim-text style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 7. (1)ヒトプレ Β細胞レセプ夕一を認識し、 且つヒトプロ Β細胞を 認識しない抗体、 （2)Vr e pB分子を認識する抗体、 （3)え 5分子を認識する抗 体、 および (4)Β細胞を認識する抗体の使用により、 小児急性リンパ性白血病が Β細胞のどの分化段階由来であるかを診断する方法。 
</span>&nbsp;7. (1) an antibody that recognizes human precellular receptors and does not recognize human progenitor cells, (2) an antibody that recognizes VrepB molecules, (3) an antibody that recognizes five molecules, and ( 4) A method for diagnosing pediatric acute lymphoblastic leukemia from Β cell differentiation stage by using an antibody that recognizes cells.
</span>
    </div>
  </claim>
</div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (3)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPS6042400A/en"><a id="link" href="#" class="style-scope state-modifier">JPS6042400A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1983-08-19</span>
                    <span class="td style-scope patent-result">1985-03-06</span>
                    <span class="td style-scope patent-result">Yamasa Shoyu Co Ltd</span>
                    <span class="td style-scope patent-result">Monoclonal antibody to human igm 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5182205A/en"><a id="link" href="#" class="style-scope state-modifier">US5182205A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1986-11-27</span>
                    <span class="td style-scope patent-result">1993-01-26</span>
                    <span class="td style-scope patent-result">Hoffmann-La Roche Inc.</span>
                    <span class="td style-scope patent-result">Nucleotide sequences which are selectively expressed in pre-B cells and probes therefor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DE3789138T2/en"><a id="link" href="#" class="style-scope state-modifier">DE3789138T2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1986-11-27</span>
                    <span class="td style-scope patent-result">1994-05-26</span>
                    <span class="td style-scope patent-result">Hoffmann La Roche</span>
                    <span class="td style-scope patent-result">
  Nucleotide sequences that are selectively expressed in pre-B cells and probes for this purpose.
 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="nplCitations" class="scroll-target style-scope patent-result">
              Non-Patent Citations (5)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      GUELPA-FONLUPT V, ET AL.: "DISCRETE EARLY PRO-B AND PRE-B STAGES IN NORMAL HUMAN BONE MARROW AS DEFINED BY SURFACE PSEUDO-LIGHT CHAIN EXPRESSION", EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY - V C H VERLAG GMBH &amp; CO. KGAA, DE, vol. 24, no. 04, 1 January 1994 (1994-01-01), DE, pages 257 - 264, XP002920269, ISSN: 0014-2980, DOI: 10.1002/eji.1830240140
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      LASSOUED K, ET AL.: "EXPRESSION OF SURROGATE LIGHT CHAIN RECEPTORS IS RESTRICTED TO A LATE STAGE IN PRE-B CELL DIFFERENTIATION", CELL, CELL PRESS, US, vol. 73, no. 01, 9 September 1993 (1993-09-09), US, pages 73 - 86, XP002920267, ISSN: 0092-8674, DOI: 10.1016/0092-8674(93)90161-I
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      MEFFRE E, ET AL.: "CELL SURFACE EXPRESSION OF SURROGATE LIGHT CHAIN (PSIL) IN THE ABSENCE OF MU ON HUMAN PRO-B CELL LINES AND NORMAL PRO-B CELLS", EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY - V C H VERLAG GMBH &amp; CO. KGAA, DE, vol. 26, no. 09, 1 January 1996 (1996-01-01), DE, pages 2172 - 2180, XP002920270, ISSN: 0014-2980, DOI: 10.1002/eji.1830260932
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      SANZ E, HERA DE LA A: "A NOVEL ANTI-VPRE-B ANTIBODY IDENTIFIES IMMUNOGLOBULIN-SURROGATE RECEPTORS ON THE SURFACE OF HUMAN PRO-B CELLS", THE JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, US, vol. 183, no. 06, 1 January 1996 (1996-01-01), US, pages 2693 - 2698, XP002920268, ISSN: 0022-1007, DOI: 10.1084/jem.183.6.2693
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      See also references of EP1001020A4
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (15)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030200839A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030200839A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-03-27</span>
                    <span class="td style-scope patent-result">2003-10-30</span>
                    <span class="td style-scope patent-result">Jenkins Alexander E.</span>
                    <span class="td style-scope patent-result">Recovery of precious metals and copper from copper/gold ores using resin technology 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6929907B2/en"><a id="link" href="#" class="style-scope state-modifier">US6929907B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-31</span>
                    <span class="td style-scope patent-result">2005-08-16</span>
                    <span class="td style-scope patent-result">North Carolina State University</span>
                    <span class="td style-scope patent-result">Methods and compositions for determining the purity of chemically synthesized nucleic acids 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030215453A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030215453A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-05-14</span>
                    <span class="td style-scope patent-result">2003-11-20</span>
                    <span class="td style-scope patent-result">Dedera Douglas A.</span>
                    <span class="td style-scope patent-result">Methods of therapy and diagnosis using immunotargeting of cells expressing VpreB1 protein 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2606190A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2606190A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-04-27</span>
                    <span class="td style-scope patent-result">2006-11-02</span>
                    <span class="td style-scope patent-result">Hw Process Technologies, Inc.</span>
                    <span class="td style-scope patent-result">Treating produced waters 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CL2007002699A1/en"><a id="link" href="#" class="style-scope state-modifier">CL2007002699A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-09-20</span>
                    <span class="td style-scope patent-result">2008-02-29</span>
                    <span class="td style-scope patent-result">Hw Advanced Technologies Inc</span>
                    <span class="td style-scope patent-result">
  METHOD THAT INCLUDES LIXIVIATE VALUABLE METAL OF MATERIAL THAT CONTAINS IT, OBTAIN LIQUID PHASE WITH ION AND FERRIC OXIDE AND ONE OF ION OR FERROUS OXIDE, PASS THROUGH NANOFILTRATION MEMBRANE, OBTAIN MORE CONCENTRATED FERTILIZATION IN ION OR OICO
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20080128354A1/en"><a id="link" href="#" class="style-scope state-modifier">US20080128354A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-11-30</span>
                    <span class="td style-scope patent-result">2008-06-05</span>
                    <span class="td style-scope patent-result">Hw Advanced Technologies, Inc.</span>
                    <span class="td style-scope patent-result">Method for washing filtration membranes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN102089004B/en"><a id="link" href="#" class="style-scope state-modifier">CN102089004B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-07-10</span>
                    <span class="td style-scope patent-result">2018-06-01</span>
                    <span class="td style-scope patent-result">东丽株式会社</span>
                    <span class="td style-scope patent-result">The treatment of cancer and prophylactic compositions 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2576636B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2576636B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-05-27</span>
                    <span class="td style-scope patent-result">2019-06-26</span>
                    <span class="td style-scope patent-result">Saudi Basic Industries Corporation</span>
                    <span class="td style-scope patent-result">Olefin gas phase polymerisation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR102590740B1/en"><a id="link" href="#" class="style-scope state-modifier">KR102590740B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-02-02</span>
                    <span class="td style-scope patent-result">2023-10-18</span>
                    <span class="td style-scope patent-result">칠드런스 헬스 케어 디/비/에이 칠드런스 미네소타</span>
                    <span class="td style-scope patent-result">
  Anti-surrogate light chain antibody
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2016127043A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2016127043A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-02-05</span>
                    <span class="td style-scope patent-result">2016-08-11</span>
                    <span class="td style-scope patent-result">Stc.Unm</span>
                    <span class="td style-scope patent-result">Anti-pre-bcr antagonists and methods 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3543697B1/en"><a id="link" href="#" class="style-scope state-modifier">EP3543697B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-03-19</span>
                    <span class="td style-scope patent-result">2021-05-05</span>
                    <span class="td style-scope patent-result">AVA Lifescience GmbH</span>
                    <span class="td style-scope patent-result">Method for the selection of biological binding molecules 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2020127827A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2020127827A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-12-20</span>
                    <span class="td style-scope patent-result">2020-06-25</span>
                    <span class="td style-scope patent-result">Ava Lifescience Gmbh</span>
                    <span class="td style-scope patent-result">Method for selecting biological binding molecules 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA3140488A1/en"><a id="link" href="#" class="style-scope state-modifier">CA3140488A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-05-02</span>
                    <span class="td style-scope patent-result">2020-11-05</span>
                    <span class="td style-scope patent-result">Ava Lifescience Gmbh</span>
                    <span class="td style-scope patent-result">Method for selecting biological binding molecules 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20220227864A1/en"><a id="link" href="#" class="style-scope state-modifier">US20220227864A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-05-02</span>
                    <span class="td style-scope patent-result">2022-07-21</span>
                    <span class="td style-scope patent-result">Ava Lifescience Gmbh</span>
                    <span class="td style-scope patent-result">Biological binding molecules 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3733709A1/en"><a id="link" href="#" class="style-scope state-modifier">EP3733709A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-05-02</span>
                    <span class="td style-scope patent-result">2020-11-04</span>
                    <span class="td style-scope patent-result">AVA Lifescience</span>
                    <span class="td style-scope patent-result">Biological binding molecules 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party, ‡ Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP5941615B2/en"><a id="link" href="#" class="style-scope state-modifier">JP5941615B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-06-29</span>
                    <span class="td style-scope patent-result">
  Method for immunological measurement of human CXCL1 protein
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN113321731A/en"><a id="link" href="#" class="style-scope state-modifier">CN113321731A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-08-31</span>
                    <span class="td style-scope patent-result">Antibodies that bind human programmed death ligand 1(PD-L1) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2007044756A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2007044756A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-04-19</span>
                    <span class="td style-scope patent-result">Monoclonal antibodies recognizing human ccr8 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1999006541A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1999006541A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-02-11</span>
                    <span class="td style-scope patent-result">Antihuman pre-b cell receptor antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2008120824A/en"><a id="link" href="#" class="style-scope state-modifier">JP2008120824A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-05-29</span>
                    <span class="td style-scope patent-result">Method for detecting dihydropyrimidine dehydrogenase and immunological material 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2871189A1/en"><a id="link" href="#" class="style-scope state-modifier">EP2871189A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-05-13</span>
                    <span class="td style-scope patent-result">High-affinity monoclonal anti-strep-tag antibody 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9823251B2/en"><a id="link" href="#" class="style-scope state-modifier">US9823251B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-11-21</span>
                    <span class="td style-scope patent-result">Anti-Uroplakin II antibodies systems and methods 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/SK154896A3/en"><a id="link" href="#" class="style-scope state-modifier">SK154896A3</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-08-06</span>
                    <span class="td style-scope patent-result">Monoclonal antibody active against cd44v6 and their use 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3650547A1/en"><a id="link" href="#" class="style-scope state-modifier">EP3650547A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-05-13</span>
                    <span class="td style-scope patent-result">Anti-human igg4 monoclonal antibody and human igg4 assay reagent using said antibody 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP3631750B2/en"><a id="link" href="#" class="style-scope state-modifier">JP3631750B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-03-23</span>
                    <span class="td style-scope patent-result">
  Monoclonal antibody against human MDR1 multidrug resistance gene product and use thereof
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN111518202A/en"><a id="link" href="#" class="style-scope state-modifier">CN111518202A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-08-11</span>
                    <span class="td style-scope patent-result">Novel coronavirus antibody and ELISA detection kit for same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN115836090A/en"><a id="link" href="#" class="style-scope state-modifier">CN115836090A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-03-21</span>
                    <span class="td style-scope patent-result">anti-CLDN 18.2 antibodies and diagnostic uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1059533A1/en"><a id="link" href="#" class="style-scope state-modifier">EP1059533A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-12-13</span>
                    <span class="td style-scope patent-result">Method for immunochemically assaying anti-hm1.24 antibody 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20060067931A1/en"><a id="link" href="#" class="style-scope state-modifier">US20060067931A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-03-30</span>
                    <span class="td style-scope patent-result">Receptor for lysophosphatidylcholine in vascular endothelial cells and use thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR102029394B1/en"><a id="link" href="#" class="style-scope state-modifier">KR102029394B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-10-07</span>
                    <span class="td style-scope patent-result">Monoclonal antibody for diagnosis of chikungunya virus infection, hybribodma producing the monoclonal antibody, and diagnosis method using the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2738250B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2738250B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-11-15</span>
                    <span class="td style-scope patent-result">Anti-beta1,6-N-acetylglucosaminyltransferase 5B antibody for detecting epithelial ovarian cancer and method for diagnosing epithelial ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN111892657B/en"><a id="link" href="#" class="style-scope state-modifier">CN111892657B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-01-31</span>
                    <span class="td style-scope patent-result">Antibody, fragment, kit and method for detecting Mi Tianbao blood group antigen 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR100493932B1/en"><a id="link" href="#" class="style-scope state-modifier">KR100493932B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-06-10</span>
                    <span class="td style-scope patent-result">Monoclonal antibody recognizing resistin, production method and use thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2011040429A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2011040429A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-04-07</span>
                    <span class="td style-scope patent-result">Monoclonal antibody against human hig-1 polypeptide 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN113214393B/en"><a id="link" href="#" class="style-scope state-modifier">CN113214393B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-11-18</span>
                    <span class="td style-scope patent-result">IL-6 antibody or antigen-binding fragment thereof and detection kit comprising same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2023223796A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2023223796A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-11-23</span>
                    <span class="td style-scope patent-result">Antibody binding to colibactin-producing escherichia coli bacterium 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH1142087A/en"><a id="link" href="#" class="style-scope state-modifier">JPH1142087A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-02-16</span>
                    <span class="td style-scope patent-result">Anti-human pre-b cell receptor antibody and its active fragment and detection of human pro-b cell 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH11133028A/en"><a id="link" href="#" class="style-scope state-modifier">JPH11133028A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-05-21</span>
                    <span class="td style-scope patent-result">Antihuman pre-b cell receptor antibody 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3665203B1/en"><a id="link" href="#" class="style-scope state-modifier">EP3665203B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-06-29</span>
                    <span class="td style-scope patent-result">Method for determining anti-drug antibodies in a minipig sample 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA3192627A1/en"><a id="link" href="#" class="style-scope state-modifier">CA3192627A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-03-03</span>
                    <span class="td style-scope patent-result">Antibodies for use in immunohistochemistry (ihc) protocols to diagnose cancer 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="applicationChildApps" class="scroll-target style-scope patent-result">
              Child Applications (1)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Relation</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6335175B1/en"><a id="link" href="#" class="style-scope state-modifier">US09/494,252</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1997-07-29</span>
                    <span class="td nowrap style-scope patent-result">2000-01-31</span>
                    <span class="td nowrap style-scope patent-result">
                        Continuation-In-Part<template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">Anti-human pre-B cell receptor antibody 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="applicationPriorityApps" class="scroll-target style-scope patent-result">
              Priority Applications (2)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1001020A4/en"><a id="link" href="#" class="style-scope state-modifier">EP98935272A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1997-07-29</span>
                    <span class="td nowrap style-scope patent-result">1998-07-29</span>
                    <span class="td style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        Antihuman pre-b cell receptor antibodies 
       <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6335175B1/en"><a id="link" href="#" class="style-scope state-modifier">US09/494,252</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1997-07-29</span>
                    <span class="td nowrap style-scope patent-result">2000-01-31</span>
                    <span class="td style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        Anti-human pre-B cell receptor antibody 
       <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (4)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        JP9/202684<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1997-07-29</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH1142087A/en"><a id="link" href="#" class="style-scope state-modifier">JP9202684A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1997-07-29</span>
                    <span class="td style-scope patent-result">Anti-human pre-b cell receptor antibody and its active fragment and detection of human pro-b cell 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        JP9/296090<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1997-10-29</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH11133028A/en"><a id="link" href="#" class="style-scope state-modifier">JP29609097A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1997-10-29</span>
                    <span class="td style-scope patent-result">Antihuman pre-b cell receptor antibody 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">1999-02-11</span>
                    <span class="td nowrap style-scope patent-result">AK</span>
                    <span class="td nowrap style-scope patent-result">Designated states</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Kind code of ref document</strong>: A1</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Designated state(s)</strong>: US</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">1999-02-11</span>
                    <span class="td nowrap style-scope patent-result">AL</span>
                    <span class="td nowrap style-scope patent-result">Designated countries for regional patents</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Kind code of ref document</strong>: A1</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Designated state(s)</strong>: AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">1999-04-15</span>
                    <span class="td nowrap style-scope patent-result">DFPE</span>
                    <span class="td nowrap style-scope patent-result">Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">1999-05-12</span>
                    <span class="td nowrap style-scope patent-result">121</span>
                    <span class="td nowrap style-scope patent-result">Ep: the epo has been informed by wipo that ep was designated in this application</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2000-01-31</span>
                    <span class="td nowrap style-scope patent-result">WWE</span>
                    <span class="td nowrap style-scope patent-result">Wipo information: entry into national phase</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 09494252</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: US</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2000-02-25</span>
                    <span class="td nowrap style-scope patent-result">WWE</span>
                    <span class="td nowrap style-scope patent-result">Wipo information: entry into national phase</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 1998935272</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: EP</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2000-05-17</span>
                    <span class="td nowrap style-scope patent-result">WWP</span>
                    <span class="td nowrap style-scope patent-result">Wipo information: published in national office</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 1998935272</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: EP</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2005-07-19</span>
                    <span class="td nowrap style-scope patent-result">WWW</span>
                    <span class="td nowrap style-scope patent-result">Wipo information: withdrawn in national office</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 1998935272</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: EP</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.1949645005" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.1949645005" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=350135567" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>